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“Show me a completely smooth operation and I'll show you someone who's 
covering mistakes. Real boats rock.” 
 
                   ~ Frank Herbert, from Dune 
   
ABSTRACT 
The formation of a multicellular body during embryonic development is one 
of the most fascinating processes in biology. The cells are in constant communication 
and must be precisely coordinated. Several essential signalling pathways have been 
identified in cell-to-cell signal transmission. One such pathway is the WNT signalling 
network, which is highly conserved and plays an important role not only in 
embryogenesis but also in the maintenance of adult tissue homeostasis. Disturbances 
of the WNT signalling system are connected to many pathophysiological processes 
including cancer, rendering this pathway a great target for pharmacological treatment. 
The aim of this thesis is to broaden our knowledge regarding the function of 
the two main components of the WNT signalling cascade: the intracellular scaffold 
protein Dishevelled (DVL) and the membrane receptors from the Class Frizzled 
(Class F).  
First, we have shown that DVL is located at the centrosome. We have 
explored the function of DVL in the regulation of the centrosomal cycle – a chain of 
events that centrosome undergoes during the cell cycle progression. DVL constitutes 
a part of the linker connecting two centrosomes that coordinate centrosomal 
separation. As a target of several kinases, DVL possesses many phosphorylation sites, 
which regulate its function and selectivity for its binding partners. We added another 
kinase to DVL’s portfolio of kinases – the centrosomal kinase Nima related kinase 2 
(NEK2). Interaction between NEK2 and DVL is important for the regulation of the 
centrosomal cycle, where phosphorylation of DVL by NEK2 displaces DVL from the 
centrosome together with other linker proteins subsequently enabling centrosomal 
separation. Therefore, DVL represents a newly identified key player in the 
centrosomal cycle.  
Next, we investigated the ability of receptors from the Class F to signal 
through heterotrimeric G proteins. We have shown that Frizzled 10 (FZD10) forms an 
inactive state complex with one specific isoform of heterotrimeric G proteins, G13, 
and this complex dissociates after addition of ligands for FZD10. Additionally, FZD10 
overexpression induced Yes-associated protein/Tafazzin (YAP/TAZ) transcriptional 
activity. We have also found that FZD10 mRNA is expressed in endothelial cells of 
the developing brain. Since G13 is a crucial molecule in vascular development, 
particularly for the endothelial cells, we propose that FZD10 signalling through G13 
 and YAP/TAZ might represent a novel signalling axis in the development of the 
central nervous system (CNS) vasculature.  
Further, we explored the structure and function of another FZD homologue, 
FZD6. We identified a triad of conserved cysteine residues in the linker region, which 
is connecting the N-terminal cysteine rich domain (CRD) with the core of the 
receptor. These cysteines are crucial for the localization of FZD6 in the plasma 
membrane as well as for its interaction with the cytoplasmic scaffold protein DVL.  
Additionally, we utilized a method involving receptor purification and 
insertion into artificial phospholipid bilayer particles to investigate the ability of 
FZD6 to directly activate heterotrimeric G proteins. We showed that FZD6 activates 
Gi as a monomeric unit by its constitutive activity. The method itself harbours great 
potential for future biochemical and pharmacological studies.  
Taken together, this thesis provides new evidence for the involvement of the 
WNT pathway components in the less investigated WNT signalling events, connects 
DVL biology with the centrosomal cycle regulation, expands the portfolio of FZD 
homologues forming an inactive preassembly complex with heterotrimeric G 
proteins, and presents FZDs as direct activators of heterotrimeric G proteins.   
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15 
1 INTRODUCTION 
1.1 WNT signalling pathways  
Communication among cells in multicellular organisms is extremely 
complex and involves many pathways. These pathways are not usually linear 
signalling events and they are subject to many regulatory mechanisms with positive 
and negative feedback loops and multiple cross-talks to other signalling networks to 
efficiently coordinate the sophisticated developmental processes. One group of these 
pathways is regulated by proteins of the WNT family. The WNT signalling network 
can be historically divided into two main signalling branches. The WNT/β-catenin 
pathway, also referred to as ‘canonical’ is the most intensively studied and also the 
best investigated, which is partially caused by the availability of well-defined 
readouts of the pathway activity. The other branch, WNT/β-catenin-independent 
signalling, sometimes called ‘non-canonical’, represents a whole network of 
signalling pathways, which are not yet well understood. Both branches of WNT 
signalling appear to antagonize each other; however, the underlying mechanisms 
remain to be elucidated (Ishitani et al., 2003; Torres et al., 1996).  
WNT signalling research started with the identification of two genes. 
In 1973, a mutant of Drosophila melanogaster lacking wings was described and 
named Wingless (wg) (Sharma, 1973). In 1982, a mouse mammary tumour virus 
(MMTV) was reported to induce mammary gland tumours by activating a gene called 
integration1 (int1) (Nusse and Varmus, 1982). A few years later it was shown that 
these two genes are homologues (Rijsewijk et al., 1987) and the name became 
a portmanteau of Wingless and integration1 – WNT (Nusse et al., 1991). 
1.1.1 WNT/β-catenin signalling 
The WNT/β-catenin pathway garnered much attention because of its role 
in the regeneration of the intestinal epithelium (Gregorieff and Clevers, 2005). It was 
discovered, that this pathway regulates proliferation and self-renewal of the intestinal 
stem cells. When impaired, it represents the main driving force for development of 
colorectal cancer (Phelps et al., 2009). More generally, this pathway is necessary for 
the maintenance of various tissues in addition to intestine, such as hair follicles or 
bones (Veltri et al., 2017). Not only homeostasis of adult tissues, but also embryonic 
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development is critically dependent on the balanced activity of the pathway. In the 
larval development of Drosophila, the WNT/β-catenin pathway controls polarity of 
body segments, where naked belts (high concentration of WNT) alternate with 
denticles (low concentration of WNT) (Bejsovec and Martinez Arias, 1991). In 
vertebrates, it is involved in the establishment of the primary body axis and anterior-
to-posterior orientation of the embryo (Hikasa and Sokol, 2013). Ectopic expression 
of the WNT-1 mRNA in the ventral blastomeres of the embryo results in body axis 
duplication (McMahon and Moon, 1989).   
The pathway uses β-catenin as the main signal transduction molecule. The 
transcriptional regulator β-catenin is present in several pools in the cell, mostly 
in adherent junctions and cytoskeleton, and a minor pool in the cytoplasm (Valenta 
et al., 2012). It is the cytoplasmic pool of β-catenin that WNT signalling uses for 
signalling purposes. Interestingly, it has been reported that the pools of β-catenin are 
Figure 1. The WNT/β-catenin pathway. (A) In the absence of WNTs, the pathway is inactive, 
β-catenin is phosphorylated and targeted for proteasomal degradation. (B) In the presence of 
WNTs, the destruction complex is disabled, β-catenin accumulates and translocates into the 
nucleus, where it regulates transcription of TCF/LEF transcription factor-regulated WNT 
target genes.   
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not completely isolated and cytoplasmic β-catenin can be released from or bound to 
the adherent junctions (Heasman et al., 1994; Maretzky et al., 2005). This opens many 
possibilities of alternative modulation of the WNT/β-catenin signalling pathway 
through extracellular cues that relate to substrate recognition or cell shape. However, 
the regulation of these events remains obscured. 
In the absence of WNTs, when the pathway is inactive, the levels of β-catenin 
in the cytoplasm are kept low (Figure 1). β-catenin is continuously phosphorylated 
by the destruction complex, which consists of the scaffold proteins AXIN (Behrens 
et al., 1998), Adenomatous polyposis coli (APC) (Munemitsu et al., 1995), Casein 
kinase 1 (CK1) (Amit et al., 2002) and Glycogen synthase kinase-3β (GSK-3β) 
(Rubinfeld et al., 1996). This phosphorylation marks β-catenin for the recruitment of 
an E3 ubiquitin ligase and subsequent proteasomal degradation (Hart et al., 1999; 
Kitagawa et al., 1999).  
Activation of the WNT/β-catenin pathway is triggered by the presence of 
WNTs, which bind to the receptor complex consisting of FZD and low-density 
lipoprotein receptor-related protein 5/6 (LRP5/6). The cytoplasmic scaffold protein 
DVL is then translocated to the plasma membrane where it interacts with FZD 
(Klingensmith et al., 1994; Tauriello et al., 2012). AXIN in complex with GSK-3β is 
also sequestered to the plasma membrane by the interaction of the DIX domains of 
DVL and AXIN. The intracellular tail of LRP5/6 is phosphorylated by the kinases 
GSK-3β (Tamai et al., 2004) and CK1 (Davidson et al., 2005), which subsequently 
leads to the inhibition of GSK-3β activity (Cselenyi et al., 2008; Stamos et al., 2014). 
GSK-3β cannot phosphorylate β-catenin anymore, therefore β-catenin accumulates 
in the cytoplasm and translocates to the nucleus. There, it acts as a transcriptional 
regulator in concert with the T-cell factor/lymphocyte enhancer factor (TCF/LEF) 
(Brunner et al., 1997; Molenaar et al., 1996) inducing expression of genes such as 
cyclin D (Shtutman et al., 1999), c-myc (He et al., 1998) and axin-2 (Jho et al., 2002). 
1.1.2 WNT/β-catenin-independent signalling 
The most recognised signalling pathways within the β-catenin-independent 
signalling cascade influence planar cell polarity (WNT/PCP pathway) and levels of 
intracellular calcium (WNT/Ca2+ pathway). In comparison to the β-catenin-
dependent pathway, these pathways modulate cell motility, migration and the 
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polarisation of tissues (Humphries and Mlodzik, 2018). They also regulate gene 
transcription, but the genes are independent from TCF/LEF transcription factors.  
There are several other pathways that are assigned to the network of 
β-catenin-independent WNT pathways: WNT/Receptor tyrosine kinase-like orphan 
receptor 2 (ROR2), WNT/Receptor-like tyrosine kinase (RYK), WNT/Mammalian 
target of rapamycin (mTOR) and WNT/Protein kinase A (PKA), but their signalling 
mechanisms are poorly understood (Schulte, 2010; Semenov et al., 2007; Sherwood 
et al., 2014).  
1.1.2.1 The WNT/PCP pathway  
PCP signalling regulates several important processes such as morphogenesis 
and tissue patterning. Most typically, it establishes polarity within the plane of the 
epithelium. The prototype tissue used to study planar cell polarity is Drosophila wing, 
because it develops from a flat single-layer epithelium (Maung and Jenny, 2011). 
However, processes employing the same conserved mechanisms were also described 
in vertebrates. For example, during convergent extension, PCP provides directional 
input leading to tissue remodelling resulting in elongation of the anterior-to-posterior 
axis (Jones and Chen, 2007). PCP also influences hair patterning and was 
characterised as the crucial pathway for the positioning of stereocilia in the inner ear 
(Jones and Chen, 2008).  
The main outcome of the PCP pathway activity is the establishment of the 
asymmetric localization of the core PCP molecules at the opposite sides of the cell 
Figure 2. Schematic overview of the PCP components and their organization in epithelial 
cells (modified from Devenport, 2014) 
19 
(Figure 2) (Peng and Axelrod, 2012). The molecular complex formed on the 
proximal side of the cell consists of Van Gogh-like protein (Vangl) and Prickle, while 
the so-called distal subset includes FZD, DVL and Diego/Inversin. The complexes 
are connected between the cells via a cadherin-like protein, Flamingo/Cadherin EGF 
LAG seven-pass G-type receptor 1 (Celsr), present on both sides of the cell (Usui et 
al., 1999). Each of the protein subsets regulates signalling events engaged in both 
positive and negative feedback loops to establish the tissue polarity (Strutt and Strutt, 
2008).  
Activation of this pathway results in signalling through small GTPases, 
RAC1 (Habas et al., 2003), RHO A (Wünnenberg-Stapleton et al., 1999) and CDC42 
(Djiane et al., 2000) and typically leads to cytoskeletal changes. The components of 
the PCP pathway are described to be upregulated in some types of cancer and given 
the fact that the pathway control cell movements it is not surprising that it promotes 
the invasiveness of cancer cells (Luga et al., 2012).  
1.1.2.2 The WNT/Ca2+ pathway  
WNT signals can also increase the intracellular levels of calcium. The typical 
calcium response triggered by G protein-coupled receptor (GPCR) activation is 
mediated by heterotrimeric G proteins. G proteins then activate phospholipase C 
(PLC), which triggers the production of diacylglycerol (DAG) and inositol 
triphosphate (IP3) from phosphoinositol diphosphate (PIP2). IP3 stimulates calcium 
channels on the membrane of the endoplasmic reticulum, resulting in the release of 
calcium ions (Ca2+). Ca2+ in turn activates calcium-dependent protein kinases, such 
as PKC, or binds to the regulatory protein calmodulin, which modulates Calmodulin-
dependent protein kinases (CaMK) (Heldin et al., 2016).  
The involvement of WNTs in calcium signalling was first demonstrated in 
Danio rerio, in which calcium release was observed after overexpression of WNT-5A 
(Slusarski et al., 1997a). Calcium fluxes control the activity of multiple kinases. The 
activation of some of them has been also reported after WNT stimulation. WNT-5A 
and FZD2 were for example shown to promote the translocation of PKC to the plasma 
membrane (Sheldahl et al., 1999), whereas WNT-5A and WNT-11 were shown 
to activate CaMKII (Kühl et al., 2000). 
The WNT/Ca2+ pathway regulates ventral cell specification, where it 
antagonises WNT/β-catenin signalling (Kühl et al., 2000). Defective calcium 
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signalling results in the dorsalization of the embryo, effect similar to overactive 
β-catenin signalling (Kühl et al., 2000; Westfall et al., 2003).  
It has been suggested that the WNT/Ca2+ and WNT/PCP signalling might 
overlap to a certain degree. First, both of them use DVL for signal transduction 
(Sheldahl et al., 2003). Second, the overexpression of Prickle, a core component of 
the WNT/PCP pathway, also mediates calcium flux (Veeman et al., 2003).  
1.2 Selected components of the WNT signalling 
pathways 
1.2.1 Frizzleds 
The frizzled gene was described for the first time in Drosophila, where its 
mutations resulted in the perturbed polarity of bristles on wings, thorax and legs 
(Vinson and Adler, 1987; Vinson et al., 1989). It was 
only several years later that FZD was characterised as a 
receptor for WNT proteins (Bhanot et al., 1996). The 
proof of WNT-FZD interaction was provided by work 
done in Schneider 2 (S2) cells, which do not respond to 
WNT by increased β-catenin stabilization, most likely 
because they do not express FZDs. Introducing FZD into 
these cells by transfection enabled WNTs to bind to the 
cell surface and activate the WNT/β-catenin pathway. 
After the human genome sequencing project was 
finished, ten homologues of the frizzled gene (FZD1-10) 
were discovered in humans and mammals and the 
phylogenetic analysis revealed their close relationship to 
Smoothened (SMO), a GPCR involved in Hedgehog 
signalling (Schulte, 2010).  
FZDs consist of one polypeptide chain that 
spans the plasma membrane seven times (Figure 3), an 
architecture typical for membrane proteins of the GPCR 
superfamily. Although architecturally similar to 
classical GPCRs, FZDs lack some of the typical 
domains, which led to their separate classification as 
Figure 3. Schematic 
representation of the FZD 
structure.  
21 
receptors in the Class Frizzled (Class F). At the N-terminus, FZDs have a cleavable 
signal sequence, which ensures its insertion into the plasma membrane. After that, 
a large and highly conserved cysteine rich domain (CRD) follows, which consists of 
roughly 120 amino acids. Since the CRD contains five disulphide bonds connecting 
α-helical stretches and β-sheets, it is considered to be structurally rigid (Dann et al., 
2001). This domain is also thought to be the main interaction site for WNTs, although 
some reports describe it to be dispensable for WNT binding (Chen et al., 2004). The 
transmembrane part consists of seven helices and forms three extracellular (ECL) and 
three intracellular loops (ICL). The ECLs contain conserved cysteines creating 
disulphide bonds, which are typical for other GPCRs where they contribute to 
receptor stabilization (Wang et al., 2006a). Moreover, they might play a role in ligand 
recognition or binding, as in other GPCRs (Lee et al., 2015). The ICLs take part in 
binding downstream components, of which interaction with DVL is one of the best 
described (Gammons et al., 2016; Strakova et al., 2017; Tauriello et al., 2012; 
Umbhauer et al., 2000). Although FZDs do not possess typical motifs for G protein 
binding that are conserved in Class A GPCRs, such as the Asp-Arg-Tyr (DRY) motif 
at the transmembrane domain (TM) 3 or NPxxxY at TM7, there are charged residues 
in the ICL3, which are known to be essential for G protein coupling in other GPCRs 
(Schulte, 2010). Right after TM7, a completely conserved KTxxxW motif has been 
identified in all FZD isoforms. This motif binds the PSD-95/Disc large/ZO-1 
homologous (PDZ) domain of DVL (Wong et al., 2003) and is essential for the 
activation of the WNT/β-catenin pathway (Umbhauer et al., 2000). Almost all FZDs 
possess another PDZ binding motif at the very end of the C-terminus, which is 
implicated in binding other cytoplasmic proteins (Wang et al., 2006a). Predictions 
showed that some of the FZD homologues can create an α-helical stretch at the 
C-terminus (Gayen et al., 2013), which has been confirmed in recent crystal structure 
of FZD4 (Yang et al., 2018). This helical structure, called helix 8, is also present 
in other GPCRs and was suggested as a determinant for G protein coupling (Wess et 
al., 2008).  
Since aberrant WNT signalling is involved in many pathological processes, 
FZDs represent a promising target for pharmacological intervention. However, the 
development of any drugs and especially small molecules, which would modulate the 
receptor activity, has been shown to be very challenging (Schulte and Wright, 2018). 
The biggest challenge is to produce ligands, which would have selective specificity 
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just for one FZD homologue. FZD homologues themselves are quite different not 
only structurally but also functionally, the modelling with the purpose of drug design 
was just partially successful due to the lack of a reliable assays for direct screening 
of the receptor activation and lack of the knowledge about the ligand binding 
mechanism (Schulte and Wright, 2018; Zeng et al., 2018; Zhang et al., 2017). So far, 
drug screens mainly relied on the dual-luciferase reporter assay for detection of the 
WNT/β-catenin signalling activity, called TOPFlash (Korinek et al., 1997), where the 
possibility for detecting off-target effects is high and the likelihood to uncover FZD 
specific drug is low.  
Progress in the drug design can be accelerated by solving the structure of 
FZD. Until recently, high resolution structural information has only been available 
for several CRD domains, including CRD of FZD8 in absence (Dann et al., 2001) or 
presence (Janda et al., 2012) of the WNT protein. FZD models of the TM core have 
been based on its close relative member of Class F, SMO, which has been crystalized 
with several small molecule ligands (Byrne et al., 2016; Huang et al., 2018; Wang et 
al., 2013, 2014). However, the crystal structure of the FZD4 transmembrane part was 
just recently solved in the ligand free state (Yang et al., 2018). The study discusses 
possible reasons for the limited progress in the design and binding of small molecules 
ligands to the TM core of FZDs. In the FZD4 homologue, the binding pocket in the 
receptor core seems to be too narrow and possibly too hydrophilic, which could 
partially explain the failed attempts at modulating FZD activity. Understanding the 
mechanism of ligand binding, having the reliable screening assay for receptor 
activation and insight into the receptor structure including CRD would greatly speed-
up the development of ligands or small molecules, which could be used as a medical 
treatment of WNT and FZD related diseases.  
1.2.1.1 FZD6 
The largest FZD, FZD6, consists of more than 700 amino acids and is 
classified in the same homology cluster as FZD3 (Schulte, 2010). These two 
homologues share higher sequence similarity, and both of them function exclusively 
in the WNT/β-catenin-independent pathways, typically in the WNT/PCP pathway.  
FZD6 regulates processes equivalent to the patterning of Drosophila cuticle, 
such as hair patterning in mice (Guo et al., 2004; Wang et al., 2006b) and together 
with FZD3 redundantly controls neural tube closure, axon growth and guidance and 
the planar orientation of hair bundles in the inner ear (Dong et al., 2018; Hua et al., 
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2014; Wang et al., 2006c). The WNT/β-catenin-dependent and -independent pathway 
act mostly antagonistically (Ishitani et al., 2003; Torres et al., 1996), probably by 
using some of the common components. In agreement with that, FZD6 serves as 
a negative regulator of the WNT/β-catenin pathway, probably by activating NEMO-
like kinase (NLK), which inhibits WNT/β-catenin signalling (Golan et al., 2004).  
Some studies suggest that FZD6 acts as a tumour suppressor by inhibiting the 
tumorigenic β-catenin pathway (Han et al., 2018; Yan et al., 2016). FZD6 has been 
implicated in the repression of gastric cancer (Yan et al., 2016). Gastric cancer cells 
exhibited decreased levels of FZD6 and overexpression of FZD6 in these cells led to 
inhibition of cell proliferation, and surprisingly, also cell migration. A similar effect 
was observed in the case of prostate cancer. Flavonoid luteolin inhibited 
WNT/β-catenin signalling by upregulation of FZD6, which suppressed stemness of 
prostate cancer cells (Han et al., 2018). On the other hand, FZD6 is sometimes 
associated with increased invasion and metastatic potential of cancer cells due to its 
ability to polarize the cells. FZD6 is frequently amplified in breast cancers where it 
was shown to regulate motility and invasion (Corda et al., 2017). Moreover, FZD6 
has been highly expressed in liver tumours (Chen, 2018), colorectal cancer (Kim et 
al., 2015) and chronic lymphocytic leukaemia where it is involved in their malignant 
progression (Wu et al., 2011). Expression of FZD6 also predicts poor prognosis for 
patients with neuroblastoma (Cantilena et al., 2011) and glioblastoma (Hirano et al., 
2014). As mentioned above, FZD6 seems to be involved in invasion and migration, 
properties connected to PCP pathway outcomes, rather than proliferation. 
The most typical human disease associated with FZD6 mutations is nail 
dysplasia. This rare recessive disorder manifests in nail malformations, which are 
occurring in highly inbred families. Several mutations in FZD6 have been associated 
with this disease: Glu584X and Arg511Cys (Fröjmark et al., 2011; Naz et al., 2012), 
Gly559Asp (Kasparis et al., 2016), Ser620Cys (Mohammadi-asl et al., 2017) and 
Gly422Asp (Raza et al., 2013). These mutations are either missense mutations or 
causing a frameshift resulting in truncated products and proteins with most likely 
impaired in membrane localization (Fröjmark et al., 2011). Further investigation of 
FZD6 in the claw and nail development showed that it regulates expression of the 
genes connected to differentiation of epidermis (Cui et al., 2013). 
Some aspects of FZD6 activation and signalling have been described by our 
group. FZD6 forms an inactive state complex with Gi and Gq but not Go, Gs and G12 
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(Kilander et al., 2014a). The FZD-G protein ‘preassembly’ is lost by uncoupling the 
FZD6-Gi complex with PTX, with agonist stimulation (WNT-5A) and seems to be 
regulated by DVL. We also showed that FZD6 is able to dimerize (Petersen et al., 
2017). The dimer dissociates upon WNT-5A stimulation resulting in increase of the 
monomer population. The monomeric receptors promote signalling through 
phosphorylated extracellular signal-regulated kinases 1/2 (ERK1/2). Dimer 
dissociation upon agonist stimulation is transient and the receptors re-associate in 
a similar time frame as ERK1/2 signalling is attenuated.    
FZD6 represents the prototype homologue for PCP signalling and even 
though it is not able to signal via β-catenin, understanding its signalling is of 
importance. Moreover, targeting of FZD6 in cancers might be favourable, since it will 
avoid the side effects caused by the disrupted β-catenin signalling.  
1.2.1.2 FZD10 
Although FZD10 belongs to the same homology cluster as FZD9 and FZD4, 
one of the most investigated FZD homologue, the research of FZD10 is lagging behind 
and gained attention primarily because of its upregulation in synovial sarcomas 
(Fukukawa et al., 2008; Nagayama et al., 2005). With the exception of placenta, 
FZD10 has not been detected in any of the adult tissues (Moriwaki et al., 2000) and 
its expression in most commonly used cell lines is extremely low. Expression of 
FZD10 seems to be rather limited to embryonic development, especially in neural 
tissues and limb buds, where it is associated with the WNT/β-catenin pathway activity 
(Galli et al., 2014; Garcia-Morales et al., 2009; Kawakami et al., 2000).  
FZD10 is highly upregulated in synovial sarcomas (Nagayama et al., 2002). 
This rare disease is a type of soft tissue sarcoma, which occurs in limbs, often in close 
proximity to the joints. Almost all synovial sarcomas are associated with 
a translocation t(X,11), resulting in a fusion protein acting as a transcriptional 
regulator (Lee et al., 1993)(Brett et al., 1997). The role of FZD10 in the development 
or progression of this disease is not clear, but signalling through the DVL-Rac1-JNK 
(c-Jun-N-terminal kinase) pathway points to an involvement of the WNT/β-catenin-
independent pathway (Fukukawa et al., 2009). Except for the upregulation in synovial 
sarcomas, FZD10 was reported to be involved also in other types of cancer, such as 
colorectal cancer (Nagayama et al., 2009; Scavo et al., 2018) and breast cancer (Gong 
et al., 2014).  
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Since FZD10 is not expressed in normal adult tissues, it seems to be 
an attractive target for a therapy, where antibodies against FZD10 are labelled with 
different radioligands in order to selectively kill the synovial sarcoma tumorigenic 
cells (Fukukawa et al., 2008; Giraudet et al., 2018; Li et al., 2018).  
1.2.2 Dishevelled 
The best described direct interaction partner for FZDs is the scaffold protein 
DVL. It plays an equally crucial role in both WNT/β-catenin-dependent 
and -independent signalling pathways as a scaffold protein and a signal transducer 
(Gao and Chen, 2010). It is speculated that DVL serves as a switch or relay among 
these pathways, but how is the signalling propagated to the downstream components 
and understanding of its ability to distinguish among different signalling branches 
remains a mystery (Mlodzik, 2016).   
DVL was discovered in Drosophila melanogaster and was named after 
a phenotype, in which the orientation of hairs and bristles is disrupted (Fahmy and 
Fahmy, 1959; Klingensmith et al., 1994). Drosophila has only one isoform of DVL 
(in Drosophila marked as DSH) compared to mammals that have three, referred to as 
DVL1, DVL2 and DVL3. These isoforms can functionally compensate for each other 
to some extent (Mlodzik, 2016; Wynshaw-Boris, 2012).   
Binding of WNT to FZDs results in phosphorylation of some of the WNT 
signalling components, including DVL. Phosphorylated DVL translocates to the 
plasma membrane, where it sequesters AXIN, a protein of the destruction complex. 
AXIN cannot serve anymore as a negative regulator in this complex, β-catenin is not 
targeted for degradation and triggers transcription of the WNT target genes.  
DVL contains three globular domains, the N-terminal DIX domain, the 
central PDZ domain and the Dishevelled, Eg-10 and Pleckstrin  (DEP) domain 
followed by a C-terminal region (Figure 4) (Gao and Chen, 2010). DIX domain is 
associated with the ability of DVL to polymerize via a head-to-tail interaction, which 
Figure 4. Schematic representation of the DVL structure. DVL contains three structured 
domains, DIX, PDZ and DEP, which are interconnected by unstructured regions.  
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is also the main mechanism of sequestering AXIN from the destruction complex 
(Schwarz-Romond et al., 2007a). The centrally located PDZ domain serves as an 
interface platform between DVL and its binding partners and was shown to directly 
interact with the KTxxxW motif present at the C-terminus of FZDs (Wong et al., 
2003). The DEP domain is assumed to interact with membrane lipids (Simons et al., 
2009) and might be responsible for membrane localization of DVL (Pan et al., 2004). 
Recently, the mechanism of the DEP function was described in more detail 
(Gammons et al., 2016; Paclíková et al., 2017). The DEP domain is responsible for 
DVL dimer formation via so-called ‘domain swapping’ between two DVL molecules 
that subsequently triggers its polymerization dependent on the DIX domain. The C-
terminus of DVL possesses a regulatory function. It can be highly phosphorylated 
and is associated with autoinhibition of DVL activity (Bernatik et al., 2011). 
Additionally, there are two other highly conserved regions (Penton et al., 2002). The 
first one, a basic region, contains conserved serine and threonine residues and is 
located between the DIX and PDZ domains. Proline-rich region is located between 
the PDZ and DEP domains. They play a role in protein-protein interactions and are 
probably involved in channelling of signals between WNT/β-catenin-dependent 
and -independent signalling.  
Originally, it was hypothesized that DVL interacts with FZD through the 
KTxxxW motif at the C-terminus of the receptor (Umbhauer et al., 2000; Wong et 
al., 2003), but additional FZD interfaces for DVL interaction were discovered. DVL 
binds motifs in the ICL3 (Tauriello et al., 2012), but DVL also interacts with a quite 
large intracellular surface on the FZD, including all three ICLs (Gammons et al., 
2016).  
Since DVL can bind such a large number of proteins, it is not clear how it 
redirects the signals among distinct branches. It might be enabled by interaction with 
its binding partners but also through posttranslational modifications. The most 
intensively studied modification is phosphorylation, which is a highly dynamic 
process. The identified kinases phosphorylating DVL are for example CK1 
(Klimowski et al., 2006; Peters et al., 1999), CK2 (Willert et al., 1997), PAR-1 
(Bernatik et al., 2011; Sun et al., 2001) and Nima related kinase 2 (NEK2) (Schertel 
et al., 2013).  
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1.2.3 FZD ligands 
For some time, scientists have been puzzled as to which ligands bind FZDs. 
This puzzle has been solved in 1996 and FZDs wre identified as receptors for 
lipoglycoproteins from the WNT family (Bhanot et al., 1996). WNTs act as 
morphogens and they are required in 
embryonic development (Nusse, 2003; 
Struhl and Basler, 1993). However, WNTs 
are also crucial regulatory molecules in 
adulthood, where WNT proteins regulate 
stem-cell renewal and tissue homeostasis 
(Pinto et al., 2003). 
Homologues of WNTs are 
evolutionary conserved within the animal 
kingdom, and 19 different WNTs have 
been identified in mammals (Wodarz and 
Nusse, 1998). The gene Wnt was first 
discovered in Drosophila melanogaster as 
a mutation causing absence of wing and 
halters (Sharma and Chopra, 1976). WNTs 
are 350 to 400 amino acids large proteins, 
containing 22 conserved cysteine residues 
involved in formation of disulphide bonds 
(Janda et al., 2012; Willert and Nusse, 2012). Such a cysteine network is sometimes 
referred to as a ‘cysteine knot’. Solving the crystal structure of Xenopus WNT-8 
together with CRD of FZD8 determined the architecture to be a two domain structure: 
a larger, N-terminal domain, resembles a ‘thumb’, and a smaller C-terminal domain 
is designated as an ‘index finger’ (Figure 5) (Janda et al., 2012). A palmitoleic acid 
modification was identified at the tip of the ‘thumb’, at Ser187 in Xenopus WNT-8 
and probably interacts with FZD’s CRD. Another interaction site of WNT with the 
CRD was described at the tip of the ‘index finger’.  
WNTs carry several posttranslational modifications such as acylation and 
glycosylation (Willert and Nusse, 2012). The function of N-glycosylation in WNT 
signalling and secretion is not clear and the number of glycosylated sites varies for 
different homologues (Doubravska et al., 2011; Komekado et al., 2007; Kurayoshi et 
Figure 5. Scheme of the WNT protein. 
The structure possesses two domains: the 
‘thumb’ and the ‘index finger’ domain, 
which are seen as the receptor contact 
points. PAM – palmitoleic acid 
(modified from Janda et al. 2012).  
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al., 2007; Mason et al., 1992). On the other hand, acylation is essential for the WNT 
activity, but the number of lipidations or the exact type of the modifications are still 
a matter of debate. Palmitate was assumed to be essential for signalling (Kurayoshi 
et al., 2007; Schulte et al., 2005; Willert et al., 2003) and palmitoleic acid for secretion 
(Takada et al., 2006). Later it was shown that signalling by WNT proteins only 
requires palmitoleic acid modification and that it is necessary to have at least one 
lipidation for secretion, regardless of its type (Tang et al., 2012). The 
acetyltransferase Porcupine catalyses the addition of the lipid (Tanaka et al., 2000) 
and only such modified WNT can associate with a transporter protein called Wntless 
(also called Evi or Sprinter), which escorts WNT to the plasma membrane (Bänziger 
et al., 2006; Bartscherer et al., 2006; Goodman et al., 2006). Recent studies suggest 
the role of the lipid moiety in dimerization of FZD CRDs (DeBruine et al., 2017), 
where the fatty acid occupies a large hydrophobic pocket created by the CRD dimers 
(Nile et al., 2017). Until the key discovery of the lipid modification on WNT 
molecules, it has been impossible to purify biologically active WNTs (Schulte et al., 
2005; Willert et al., 2003). Addition of relatively high concentrations of detergents 
(particularly CHAPS) during the extraction process overcame the challenge. In 
general, WNT proteins seem to be relatively unstable. Importantly, tagging WNTs 
also decreases their stability and therefore careful placement of the tag and 
monitoring WNT activity is required (Schulte et al., 2005). An additional modulation 
of WNT activity is mediated by trans-membrane WNT-specific metalloproteases, 
TraB domain containing-protein 2A and 2B, known as Tiki1 and Tiki2 respectively, 
that cleave the N-terminus of WNT proteins leading to WNT inactivation (Zhang et 
al., 2012, 2016). 
WNTs can have either a short or long operational range. For short range, 
WNTs are probably still associated to the membrane of the secreted cell and can act 
on the same or the neighbouring cell (Farin et al., 2016). WNTs can also travel on 
filopodia-like protrusions, called cytonemes (Holzer et al., 2012). For long range, the 
lipid moiety needs to be shielded in the aqueous solution. Several proteins possessing 
the transporter role have been discovered. The protein Swim facilitates the 
extracellular diffusion of WNT in the Drosophila wing disc (Mulligan et al., 2012). 
Similarly, an albumin-like serum component, Afamin, associates with WNT-3A 
secreted into the culture media (Mihara et al., 2016). Interestingly, secreted FZD-
Related Proteins (sFRP), which are considered to sequester WNTs and therefore 
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inhibit WNT signalling, also appear to be able to transport them (Bovolenta et al., 
2008; Mii and Taira, 2009). For long range transport, WNTs can also be inserted into 
lipid containing membranous particles such as exosomes (Luga et al., 2012), high- 
and low-density lipoproteins (Neumann et al., 2009) and vesicles called argosomes 
(Greco et al., 2001). Moreover, WNTs associate with extracellular matrix 
components especially to glycosaminoglycans (Bradley and Brown, 1990; 
Reichsman et al., 1996), which maintain their solubility and support their ability 
to signal (Lin, 2004).  
The 19 different WNTs can bind to ten different FZD homologues and 
selectivity of their interaction still remains to be elucidated. It is also not completely 
clear how cells can respond to specific WNT expression patterns of multiple WNTs, 
which sometimes have opposing biological effects. One theory is that FZDs require 
a specific co-receptor, which would confer the specificity for each WNT. Such 
an example can be FZD4 interaction with Norrin enabled by LRP5/6  and Tetraspanin 
12 (TSPAN12) during retina vascularization (Lai et al., 2017). 
It was surmised that WNTs are the only extracellular ligands that bind FZDs, 
but over time other proteins have been identified as FZD ligands. For example, sFRPs 
belong to a family of secreted modulators of the WNT signalling pathway. Although, 
they are considered to be mainly WNT binding molecules, it has been shown that 
they also serve as ligands for FZDs (Üren et al., 2000). Another ligand, Norrin, is 
specific just for FZD4 (Xu et al., 2004). Although it contains a cysteine knot motif, 
Norrin is not related to the WNTs. Norrin was identified to cause the Norrie disease, 
an eye disorder caused by impaired retinal development. Mice with a mutation in 
FZD4 exhibited phenotypes similar to mice with a Norrin mutation (Berger at all 
1996). The accessory protein TSPAN12 has been reported as a component of the 
Norrin-FZD4 complex and directly associates with Norrin-FZD4 maximal signalling 
capacity (Lai et al., 2017). Recent findings pointed out that FZD1, FZD2 and FZD7 
can bind the toxin B (TcdB) produced by Clostridium difficle (Tao et al., 2016). 
Association of TcdB was shown to compete for binding with WNTs and can block 
the WNT mediated signalling through β-catenin. 
1.3 The centrosome 
Eukaryotic cells possess many organelles to ensure its proper functionality. 
Some of them are indispensable, some of them seem to be dispensable in certain cell 
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types or organisms. The centrosome belongs to these mysterious organelles. It is 
present in almost all metazoan cells apart from oocytes (Szollosi et al., 1972). 
Interestingly, plants also lack centrosomes but they have developed alternative 
mechanisms taking over the centrosomal functions (Schmit, 2002). 
Centrosomes can perform a variety of tasks in different cell types during the 
progression of the cell cycle. One of the main functions is anchoring and nucleating of 
microtubules hence also the name microtubule organizing center (MTOC) (Wu and 
Akhmanova, 2017). The microtubules are in charge of transporting cargo within the 
cell to maintain the cell shape. Thus, the centrosome acts as a crucial determinant in 
these processes. Similarly, two centrosomes regulate the assembly of the bipolar mitotic 
spindle during mitosis. Since the centrosomes do not only influence the formation 
of kinetochore microtubules, but also the orientation of the mitotic spindle itself, it has 
a role in asymmetric cell division and cell fate determination (Yamashita, 2009). 
Besides the mitotic spindle assembly, centrosomes contribute to the progression of the 
cell cycle by concentrating signalling molecules and regulators of cell division 
(Schatten, 2008). However, the centrosome has a function also in cells, which do not 
undergo cell division. In these quiescent cells the centrosome can associate with the 
plasma membrane and transform into the basal body giving rise to cilia or flagella 
functioning in cellular motility and as signal transduction hubs (Marshall, 2008).   
Depletion of centrosomes has different effects, depending on the stage when 
they were lost. Drosophila embryos that completely lack centrosomes die after a few 
cell divisions (Basto et al., 2006). If the centrosomes are depleted later within the 
embryonic development, the embryos are able to go through the whole embryogenesis, 
with just slight delay. However, the flies die after birth due to the lack of cilia. Cilia 
function as chemo- and mechanosensors thus movements of cilia-deficient flies are 
uncoordinated, and so they cannot feed. Similarly to Drosophila, mouse embryos 
lacking the centrosomes are very small and the development arrests at embryonic day 
9 (E9) accompanied by dramatic apoptosis (Bazzi and Anderson, 2014).  
The centrosome consists of pericentriolar material assembled around two 
centrioles (Bornens, 2012). The two centrioles, denoted as a mother and daughter 
centriole, are positioned perpendicularly to each other. When the daughter centriole 
starts to form, the first assembled structure is a nine-fold symmetric structure, 
a structure of a cartwheel, composed of proteins spindle assembly abnormal protein 
6 homologue (SAS-6), centrosomal protein of 135 kDa (CEP135) and SCL-
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interrupting locus protein (STIL) (Kitagawa et al., 2011). During the centriole 
growth, this structure is elongated through the deposition of centriolar microtubules 
around the cartwheel. The centrioles accumulate pericentriolar material, layers of 
proteins including CDK5 regulatory subunit-associated protein 2 (CDK5RAP2) and 
pericentrin, which recruit and activate γ-tubulin ring complexes (γ-TuRC) anchoring 
and nucleating microtubules (Zimmerman et al., 2004).  
Like the genome, the centrosome also duplicates once per cell cycle 
(Figure 6) (Bettencourt-Dias and Glover, 2007). The cells in the G1 stage contain 
just one centrosome with two centrioles connected by a protein called cohesin. During 
the S phase, the centrioles separate and duplicate. Entering G2, the cells harbor two 
centrosomes, each containing two centrioles. These two centrosomes are transported 
to the opposite ends of the cell during mitosis and each of them becomes segregated 
into the newly formed cells making it possible to enter a new cell cycle.  
In order to trigger the nucleation of new centrioles, and thus the duplication 
of the centrosome, the centrioles must separate in the first phase of the cell cycle, the 
G1 phase. The mother centriole is partially disconnected from the daughter by 
cleavage of cohesin connecting the centrioles (Schöckel et al., 2011; Tsou et al., 
Figure 6. Schematic presentation of the centrosomal cycle. A – G1 stage of the cell cycle 
when the cells possess just one centrosome with two centrioles. B – separation and C – 
duplication of centrioles during the S phase of the cell cycle. D – duplicated centrosome 
connected by the protein linker in G2 phase. E – disengaged centrosomes in the mitosis 
(inspired by Mardin and Schiebel, 2012).  
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2009). Cleavage is enabled by the proteolytic activity of separase and modulated by 
polo-like kinase 1 (PLK1) (Tsou et al., 2009). The separation is required for the next 
phase, the nucleation and elongation of daughter centrioles, which are regulated by 
polo-like kinase 4 (PLK4). Each of the separated centrioles give rise to one new, 
perpendicularly attached daughter centriole. After the centrioles are duplicated, the 
centrosomes can be disengaged. The centrioles were separated in a previous step by 
cleavage of cohesin, but they are still connected by a ‘loose linker’ (Bornens et al., 
1987) consisting of proteins including Centrosomal Nek2-Associated Protein 1 (C-
NAP1), Rootletin, and the kinase NEK2. The proximal ends of the centrioles are 
decorated with C-NAP1 and NEK2 (Fry et al., 1998), which serve as anchor points 
for Rootletin that physically connects both centrioles (Bahe et al., 2005). In the G2 
phase, NEK2 phosphorylates C-NAP1 (Fry et al., 1998) and Rootletin (Bahe et al., 
2005), which triggers their removal from the centrosome. After disengagement, the 
centrosomes are physically separated by the action of the kinesin motor Eg5 (Blangy 
et al., 1995) that is mediated by the Aurora A - PLK1 kinase cascade. PLK1 not only 
stimulates separase for the cohesin removal in one of the previous steps, but it also 
regulates activity of NEK2 and triggers action of kinesin related motor protein Eg5 
together with Cyclin dependent kinase 1 (CDK1) (Mardin and Schiebel, 2012).  
Since the discovery of the centrosome by Flemming and Boveri, it was 
surmised that centrosomal aberrations are associated with tumorigenesis (Godinho 
and Pellman, 2014). Indeed, multipolar mitoses are often observed in tumour cells. 
An aberrant number of centrosomes leads to chromosome instability, and thus 
promotes the tumorigenesis (Basto et al., 2008). Individuals with defects in 
centrosomes suffer from developmental disorders affecting the brain function such as 
primary autosomal recessive microcephaly (Nigg et al., 2014) or the entire body 
resulting in dwarfism (Klingseisen and Jackson, 2011). Additionally, several diseases 
broadly classified as ciliopathies are associated with malfunction of the centrosome-
associated structure, the primary cilium (Fliegauf et al., 2007). 
The importance of the centrosome in coordination and regulation of the cell 
cycle and implication of the centrosome in aneuploidy and tumorigenesis are 
considered as important targets for anti-cancer drugs (Venghateri et al., 2015). 
Several compounds targeting the centrosomal proteins, exclusively kinases, have 
been developed. They are still in preclinical phase or early stages of clinical trials. 
However, they represent a promising avenue to achieve tumour suppression.   
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1.4 Angiogenesis in the CNS 
The formation of new blood vessels occurs via two mechanisms. De novo 
formation of blood vessels during embryogenesis, where endothelial precursors 
(angioblasts) migrate and differentiate, is called vasculogenesis. In the second type 
of the blood vessels formation, angiogenesis, endothelial cells sprout from the pre-
existing vessels.  
Vascularization of the CNS is mediated entirely by angiogenesis. It starts at 
E8.5 - E9.5 when angioblasts differentiate and form a network of vessels called 
perineural vascular plexus (PNVP) around the neural tube. Around E9.5, the sprouting 
from the PNVP invades the neuroepithelium following the proangiogenic signals such 
as Vascular endothelial growth factor A (VEGF-A). The CNS has the highest 
requirements for oxygen and nutrient supply and it is also very sensitive to toxic agents. 
To prevent CNS damage, the endothelial cells establish a special protective layer, called 
blood-brain barrier (BBB).  
The BBB has very strict requirements for a well-organized system of tight 
junctions between the endothelial cells. Many molecules cooperate to prevent the free 
flow of substances between CNS and blood, including claudins, occludins, junctional 
adhesion molecules and endothelial selective adhesion molecules (Dejana 2004). The 
mature BBB capillaries are further covered by a high number of pericytes embedded 
in a common basal membrane together with astrocytic end-feet that are indispensable 
for regulation of the selective BBB permeability (Armulik et al., 2010). There is an 
obvious need for a vivid communication between neural tissue and the circulation. 
Therefore, there are many specialized molecules in the endothelial cells of the BBB 
that enable transport of substances, such as ATP binding cassette transporter family 
(ABC) or glucose transporter-1 (GLUT1) that are considered to be one of the earliest 
BBB markers (Liebner and Plate, 2010). It is not exactly clear, when the BBB is 
established during embryonic development. Initially it was thought that it is formed 
after invasion and remodelling of vessels to the CNS. However, recent reports argue 
that angiogenesis and establishment of the BBB happen simultaneously (Umans et 
al., 2017). 
The profound understanding of the underlying mechanisms of BBB function 
is of utmost interest, since BBB dysfunctions are associated with human diseases such 
as stroke, brain tumours and multiple sclerosis. The investigation of BBB function in 
more detail will enable a more effective treatment of patients affected by BBB defects.  
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1.5 G protein-coupled receptors and heterotrimeric 
G proteins 
GPCRs are the largest class of membrane proteins encoded in the human 
genome. They play a central role in many physiological processes including sense 
of vision, taste and olfaction, cell survival, proliferation, differentiation, chemotaxis 
and cell-cell communication (Hall et al., 1999; Pierce et al., 2002). The diseases 
connected to impaired function of GPCRs range from obesity, heart failure, asthma, 
schizophrenia to cancer.   
GPCR represent a suitable drug targets due to their involvement in a large 
number of (patho)physiological processes as well as their cell surface localization. 
The feasibility of GPCRs for medical intervention is highlighted by the fact that up 
to 60% of prescribed pharmaceuticals target GPCRs directly or indirectly 
(Overington et al., 2006; Rask-Andersen et al., 2011). The world-best selling drugs 
includes Advair Diskus for asthma treatment, a drug combining steroids with long 
acting β2 adrenoreceptor agonists, and Abilify, a partial agonist for several GPCRs, 
for treatment of schizophrenia.  
Activation of GPCRs can be triggered by various extracellular ligands such 
as photons, ions, nucleotides, amines, odorants, lipids, peptides and proteins (Wacker 
Figure 7. The initial process of G protein activation by GPCR. After agonist binding, the 
receptor establishes a ternary complex with G protein. The GDP bound between the RAS and 
AHD is released and exchanged for GTP (modified from Rasmussen et al. 2011).  
35 
et al., 2017). In response to the signals, GPCRs undergo a conformational 
rearrangement, which results in activation of downstream molecules. In the classical 
GPCR signalling pathway, the activation translates into signalling through 
heterotrimeric G proteins, however, GPCRs can also interact with other cytoplasmic 
scaffold proteins, such as β-arrestins.  
Heterotrimeric G proteins consist of three subunits, α, β and γ. The α subunit 
possesses two distinct domains, the RAS and α-helical domain (AHD), where the 
RAS domain associates with the receptor and AHD has quite large flexibility 
(Rasmussen et al., 2011). The guanine nucleotide binding site for GDP or GTP is 
located between them. The G proteins are classified in four different groups, Gs, Gi/o, 
Gq/11 and G12/13 (Milligan and Kostenis, 2006). Each of them is having specific 
signalling outcomes including regulation of adenylyl cyclase, signalling through 
RHO kinases or mobilization of calcium. 
For heterotrimeric G proteins, GPCRs serve as guanine nucleotide exchange 
factor (GEFs) facilitating the exchange of GDP for GTP (Figure 7). The nucleotide 
exchange is accompanied by the structural rearrangements in both, the heterotrimeric 
G protein and the receptor. It results in a dissociation of the α subunit from βγ subunits 
and activation of the G protein. A closer look at the α subunit during activation reveals 
that its C-terminal α5 helix in the RAS domain is protruding into the GPCR cavity 
upon association with the active receptor, where it interacts with TM5 and TM6 
causing an outward move of TM6 (Carpenter and Tate, 2017). The AHD moves away 
from the RAS domain allowing a wide opening. This opening is necessary for the 
release of GDP from the nucleotide binding site. However, the exposure of the 
nucleotide binding site alone is not enough for nucleotide release, and it is expected 
that other structural rearrangements, especially in the RAS domain are required for 
nucleotide dissociation (Dror et al., 2015). The nucleotide free state of the G protein 
is short-lived in cells because of the high intracellular concentration of GTP, which 
rapidly associates with the α subunit causing dissociation of βγ. Then, the G protein 
passes the signal further to effector molecules such as adenylyl cyclase and 
phospholipases. In order to limit the lifetime of the G protein signal, the α subunit 
possesses an intrinsic GTPase activity, which enables the hydrolysis of GTP back to 
GDP. This mechanism, together with the action of the regulators of G protein 
signalling (RGS), ensures reliable ‘switch off’ of the G protein and enables the re-
association with the βγ subunit.  
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Several models were developed in 
order to better understand the role of G 
proteins for receptor activation. In the two-
state model, where the G protein is not 
included, the receptor is presented in the 
resting state (R) and activated state (R*), 
which exist in equilibrium. Without any 
ligand, the equilibrium is usually strongly 
shifted towards R. Agonists have higher 
affinity for R* and thus they shift the 
equilibrium towards R*. The discovery of 
the ability of heterotrimeric G protein to act 
a as positive allosteric modulator, meaning 
that it is able to increase the binding of the 
agonist to the receptor, motivated the 
upgrade of the simple two-state model to 
the ternary complex model (Figure 8) (De 
Lean et al., 1980). The revised model does not only take the interaction between 
a ligand and its receptor but also the active receptor and G protein into account. It 
gives rise to a four-point 2D model – a ternary complex model, where the G protein 
serves as a regulatory component and establishes the high affinity agonist-receptor-
G protein complex. In this state, no nucleotide is bound and is referred to as the active 
state. However, the regulatory component can be represented by other molecules, for 
example ligands binding to other than the primary (so-called orthosteric) site of the 
receptor, thus modulating its affinity to the orthosteric ligands. Alternatively, such 
a regulatory unit can be also represented by β-arrestin.  
Initially, β-arrestin binding to the receptor and β-arrestin-mediated 
endocytosis were seen as a mechanism of desensitization of GPCR signalling 
(therefore the name ‘arrestin’ depicting signalling arrest) (Lohse et al., 1990). 
However, except for desensitization and internalization of GPCRs, they also facilitate 
their own mode of signalling that can be initiated independently or right after 
G protein activation. 
The typical structure of GPCRs presents with seven transmembrane passing 
helices, thus the name 7-transmembrane receptor. Since the GPCR superfamily 
Figure 8. A ternary complex model. H – 
hormone (ligand), R – receptor, X – 
additional component (G protein). The G 
protein is required to establish a high 
affinity complex of receptor with bound 
ligand (HRX) (modified from DeLean et 
al., 1980).  
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includes up to 800 members, they have been divided into six classes, A-F 
(Kolakowski, 1994). Recently, a newer classification was created to better reflect the 
phylogenetic relationship organizing them into five families: Glutamate, Rhodopsin, 
Adhesion, FZD/Taste2 and Secretin, forming the ‘GRAFS’ classification system 
(Foord et al., 2005; Schiöth and Fredriksson, 2005). Each family possesses some 
unique domains, structures or features. For example, the DRY motif at the TM3 or 
NPxxxY are typical determinants for the Rhodopsin family (Audet and Bouvier, 
2012). The secretin family possesses an N-terminal extracellular domain (ECD), 
which binds mainly polypeptide hormones (Hollenstein et al., 2014). Representatives 
of the glutamate family (Class C) has a large N-terminus containing a conserved 
venus flytrap domain (VFD) and a CRD (Chun et al., 2012). Adhesion family 
receptors possess a domain, which undergoes proteolysis (Araç et al., 2012).  
Crystal structures of GPCRs, especially in complex with G proteins have 
greatly contributed to a better understanding of their function. Rhodopsin was the first 
GPCR to be crystallized (Palczewski et al., 2000). It is highly enriched in the retina 
and thus, bovine retina was used as a natural source of this receptor for purification. 
However, other GPCRs are usually only present in natural sources in small quantities, 
which is one of the reasons why it took another seven years to obtain the crystal 
structure of the second GPCR, the β2 adrenergic receptor (Rasmussen et al., 2007). 
Since then, around 200 structures of more than 30 distinct GPCRs have been 
published and they have a remarkable influence on the design of the new drugs 
(Pándy-Szekeres et al., 2018).  
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2 AIMS 
The general aim of this thesis is to extend the knowledge about the WNT 
signalling pathway in the less conventional cellular processes and signalling events. 
The focus was mainly on two of the components, DVL and FZD.  
 
The specific aims were to: 
 
• Investigate the role of DVL in centrosome regulation 
• Examine whether FZD10 interacts with and activates heterotrimeric 
G proteins 
• Examine, which downstream signalling pathways are initiated by 
a putative FZD10-G protein complex 
• Dissect the role of the CRD and linker domain in FZD6 functionality 
• Investigate the ligand dependency of the FZD-DVL interaction 
• Optimize FZD6 purification and incorporation of the purified 
receptor into artificial phospholipid bilayer particles (rHDL) 
• Investigate guanine nucleotide exchange activity of purified FZD6 
towards heterotrimeric G proteins 
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3 METHODS 
3.1 Fluorescence recovery after photobleaching 
Different methods can be used to visualize and analyze dynamic cellular 
processes. One such technique is the fluorescent recovery after photobleaching, 
FRAP. It allows to observe lateral mobility of the fluorescently tagged membrane 
proteins, but it can be also modified to monitor the association of two molecules.  
The principle of FRAP is based on the observation of the fluorescent intensity 
in a small region in the cell. In this region of interest (ROI) the fluorescent molecules 
are irreversibly bleached by a high intensity laser beam. Subsequently, the diffusion 
of the non-bleached proteins from the surroundings into the bleached area leads to 
recovery of the fluorescence over time. The speed and extent of the fluorescence 
recovery depend, among other parameters, on the size and the lateral mobility of the 
protein of interest. If the protein is highly mobile, the bleached area will recover 
quickly. If only a fraction of the molecules is mobile, only partial recovery of the 
fluorescent signal can be measured. If the protein is immobile, no recovery is 
detectable. 
Figure 9. A schematic presentation of the dcFRAP methodology. The green molecule was 
immobilized (for example by crosslinking). The mobility of the red molecule is investigated. 
Free mobility (therefore no association) results in full recovery in the postbleach time course 
– represented by the scheme. (In case of association, no or partial recovery would be 
observed).  
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Monocolor FRAP was modified for observation of two colours, thus 
dual-colour (dc) FRAP was developed (Figure 9). DcFRAP can be used for the 
observation of association of two molecules (Picard et al., 2006). The two molecules 
are fluorescently labelled with different fluorophores. Typically, one of the target 
molecules is immobilized by crosslinking. In case of the receptor, the crosslinking 
can be achieved chemically by application of membrane impermeable small 
molecules (for example EZ-link-sulfo-NHS-LC-LC-biotin), which crosslinks the 
primary amines of the membrane proteins. The small area in the membrane is 
bleached resulting in reduced signal from both fluorophores. The crosslinked protein 
will not exhibit any diffusion and therefore minimal recovery of the corresponding 
fluorophore is detected. If the other observed molecule is associated, it will exhibit 
retardation in its mobility. If the two molecules do not interact, the fluorescence of 
the mobile protein is identical to the situation when it is expressed alone.  
It should be noted that this method can detect only the state of the 
non-activated GPCR with the G protein, termed as preassembly state. This interaction 
dissociates after addition of an appropriate ligand. It is unable to detect collision 
coupling, where freely mobile molecules couple by random collision.  
The dcFRAP method was used in paper II to investigate the association of 
FZD10 with heterotrimeric G proteins.  
3.2 Dynamic mass redistribution 
Many of the traditional GPCR assays dissect the signalling into separate 
pathways or signalling events, such as stimulation of the adenylyl cyclase or 
mobilization of calcium. However, receptor response to a stimulus can be more 
complex and can modulate more than one signalling event at a time. Thus, especially 
for the investigation of drug effects, it is advantageous to combine classical assays 
with approaches monitoring the overall response of the cells such as dynamic mass 
redistribution (DMR) technique.  
DMR monitors changes in the localization (redistribution) of the 
biomolecules in the cells in real time. The redistribution can be caused by receptor 
stimulation and triggers various cellular processes such as protein trafficking, 
cytoskeletal rearrangements and receptor internalization. The changes are assessed in 
a plate reader system, where the cells are seeded on a specialized plate with 
waveguide-grating embedded in its bottom. The grating interacts with the cells on its 
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surface and forms an optical system. After illumination with broadband light, it can 
propagate and reflect a specific wavelength, which is in resonance with the system 
(Figure 10). The resonance of the optical system to a specific wavelength depends 
on the optical density of the cell layer. When the tested compound is added, the optical 
density changes as a consequence of the cellular change in shape due to the 
redistribution of the intracellular compounds. An increase in optical density is caused 
by more tight association of the cells to the surface and results in the increase of 
the reflected wavelength, thus producing a positive DMR signal. Similarly, a decrease 
in DMR reflects the reduction in optical density and decrease in the reflected 
wavelengths.  
DMR can monitor activation of GPCRs, including activation of all G protein 
families (Gi/o, Gs, Gq/11 and G12/13) (Schröder et al., 2010). The DMR traces can 
be indicative of the specific cellular responses, because the mass redistribution is not 
random. In paper II, we employed DMR to assess signalling by FZD10 stimulation 
through G13.  
3.3 Production and purification of a GPCR 
Purification of membrane proteins is considered to be a challenging 
procedure. However, it is a necessary step for obtaining the structural information. 
The purified protein can be reconstituted into phospholipid bilayer particles (rHDL 
particles), which can be used for structure determination or for functional studies such 
as ligand binding assay or activation of G proteins.  
Figure 10. The principle of DMR. A cell seeded on the bottom of the DMR plate with the 
glass bottom containing the waveguide-grating. The bottom is illuminated with broadband 
light. Specific wavelength is reflected and detected (modified from Fang et al., 2007) 
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Since GPCRs are generally not highly expressed in tissues, they cannot be 
obtained in sufficient amounts from natural sources. Perhaps, the only exception is 
rhodopsin, the first crystallized GPCR, which is abundant in the retina (Palczewski 
et al., 2000). Thus, the design of recombinant GPCRs possessing suitable purification 
tags in combination with a suitable production system is essential.  
Several systems have been developed and used for production of suitable 
amounts of GPCRs. The most common expression system used for GPCR production 
is based on insect cells, especially the SF9 cells (Spodoptera frugiperda) and the 
HighFive cells (Trichoplusiani) infected with baculovirus carrying a gene for GPCR 
expression. Insect cells allow to produce high yields of GPCRs. In comparison 
to mammalian cells, the composition of the cell membranes is slightly different with 
low amount of cholesterol, but they possess similar posttranslational modifications. 
A caveat of this system can be a higher proportion of a misfolded receptor compared 
to mammalian systems (Thomas and Tate, 2014). Mammalian expression systems are 
the most suitable for receptor production because the composition of the cell 
membrane fits the mammalian proteins and post-translational modifications (PTMs) 
match the host organism. Mammalian cells have been used for both, stable and 
transient transfections. GNTI- human embryonal kidney (HEK) 293 cells lacking the 
N-acetylglucosaminyl-transferase I activity and thus lacking complex N-glycan 
modification have gained popularity especially for crystallization purposes. 
However, the mammalian cell system is also the most expensive. Alternatively, 
GPCRs can be expressed in yeast and bacteria, facing problems with PTMs and 
a different cell membrane composition.  
In order to extract the receptor from the cells, the cells must be disrupted. For 
mammalian and insect cells, an incubation in hypotonic buffer or the disruption 
by nitrogen cavitation are used for membrane preparation. The nitrogen cavitation 
provides a better separation of the outer plasma membrane containing rather mature 
receptor from the internal (endoplasmic reticulum and Golgi apparatus) membranes 
containing also fraction of an immature receptor. After cell disruption, the receptor is 
solubilized in suitable detergents, which extract the transmembrane proteins from the 
lipid bilayer. The detergent must be efficient enough to extract the receptor from the 
membrane but mild enough to maintain receptor structure. The most commonly used 
detergent for GPCRs is n-dodecyl β-D-maltoside (DDM) (Vanaken et al., 1986) and 
the more recently developed lauryl maltose neopentyl glycol (MNG) (Chae et al., 
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2010). MNG is more tightly associated with the receptor and provides better stability 
and is therefore less suitable for embedding the protein into nanodiscs, where the 
detergent must be stripped off the protein during reconstitution.  
 The protein purification procedure usually consists of several steps. The first 
one is typically purification with immobilized metal-ion affinity chromatography 
(IMAC) with either cobalt or nickel ion resins, which bind HIS tags present on the 
protein. Alternatively, affinity purifications are performed via FLAG or 1D4 epitope 
tags and corresponding antibodies. The next steps include the ion-exchange 
purification, based on the charge of the protein. The final purification step is often 
done with size exclusion chromatography, where the proteins are separated according 
to their size. The purification steps can be supplemented with affinity 
chromatography employing immobilized ligand, where the folded, ligand-binding 
receptors are separated from the unfolded ones. After the purification, the purity and 
the amount of protein are monitored by detecting of the total protein levels in a PAGE 
by silver or Coomassie staining.  
In paper IV, we used different production and purification strategies, which 
were mostly limited by the amount of produced and bound protein. For reconstitution, 
usually IMAC or IMAC in combination with FLAG purification were used.    
3.4 rHDL particles preparation 
Once the membrane proteins are isolated and removed from their native 
environment, the cell membrane, they tend to unfold and aggregate. In order to extract 
and stabilize the membrane protein in solution, the usage of suitable detergents is 
important to preserve the protein structure. However, some membrane proteins still 
exhibit poor stability after detergent solubilization. They also might have different 
signalling properties (Bai et al., 2016). Moreover, the detergents could be 
incompatible with certain biochemical or pharmacological assays. In order to 
overcome these problems, membrane proteins can be further stabilized in lipid 
bilayers to mimic their native environment. The membrane proteins can be 
reconstituted into liposomes, spherical vesicles with a lipid bilayer. However, it is 
difficult to control for receptor orientation, stoichiometry and the size of liposomes. 
These problems were overcome by insertion of membrane proteins into planar discoid 
lipid particles. These particles, denoted as reconstituted high-density lipoprotein 
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(rHDL) particles or sometimes nanodiscs, come with the advantages for the 
investigation of membrane proteins including GPCRs (Jonas, 1986).   
The structure of rHDL particles is based on physiologically occurring HDL 
particles in the human body. The native HDL particles are present in the plasma and 
blood and they participate in cholesterol homeostasis. They collect the excess 
of cholesterol from the periphery and transport it back to the liver for disposal 
(Rothblat and Phillips, 2010). HDL particles consist of phospholipids, the 
amphipathic protein Apolipoprotein AI (Apo AI) and the cargo cholesterol. They can 
either exist in nascent discoidal form or in the mature spherical form, which is 
predominant in the plasma.  
The rHDL particles prepared in vitro are small discoidal particles of about 10 
nm in size (Timothy H. Bayburt et al., 2002). They consist of synthetic phospholipids, 
which are surrounded by two molecules of the membrane scaffold protein (MSP) (Li 
et al., 2006; Timothy H. Bayburt et al., 2002). The 
MSP is the genetically engineered Apo AI, where 
the N-terminal globular domain, which does not 
interact with the phospholipids, was removed. 
The removal results in particles with more 
uniform size (Denisov et al., 2004). In the past, 
molecules such as ion channels (Autzen et al., 
2018; Matthies et al., 2018), receptor tyrosine 
kinases (Mi et al., 2008), the P450 reductase 
(Bayburt et al., 1998) and also several GPCRs, 
from which the first was the β2 adrenergic 
receptor (Leitz et al., 2006), were successfully 
embedded in rHDL.   
There are several ways how to 
‘reconstitute’ (embed) the membrane protein into 
the rHDL particles. Membranes containing the 
protein of interest are solubilized in the detergent in presence of phospholipids and 
MSP. Obviously, this will produce particles carrying also other membrane proteins. 
Therefore, a subsequent purification of the target protein in the rHDL might be 
necessary. Another way to produce rHDL particles carrying membrane proteins is to 
purify the protein in a detergent, prior to the insertion into the particles. The particles 
Figure 11. Idealized picture of 
a  rHDL particle with embedded 
receptor (in blue). Phospholipids 
(in yellow) are surrounded by the 
two MSP/Apo AI molecules (red).  
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will be formed by self-assembly when the detergent is removed. The removal is 
usually done by dialysis or by adsorption of the detergent to porous hydrophobic 
beads (also termed as Bio-Beads). The target membrane protein simultaneously 
assembles with phospholipids into a discoidal bilayer (Figure 11). The size of the 
particles is controlled by the length of MSP. During the reconstitution, an important 
parameter is the lipid to MSP ratio. Too little lipids will result in deformed particles 
with poor lipid content. In contrast, too much lipids can form larger particles or 
occasionally particles containing more than two MSP proteins per particle 
(Brouillette et al., 1984).  
The nanodisc keeps the membrane protein in solution in absence of 
a detergent, provides a native-like phospholipid bilayer environment and ensures 
membrane protein stability and functionality. The lateral diffusion of proteins is 
limited by the size of the MSP. Moreover, the extracellular and the intracellular sides 
of the protein are accessible and also allows for the control of the oligomeric state of 
the target membrane protein. The rHDL particles have been used for many 
biochemical assays, such as surface plasmon resonance (SPR), radioactive ligand 
binding, G protein activation assay [35S]GTPγS, single molecule spectroscopy and 
mass spectroscopy (Bayburt and Sligar, 2010). Their biggest potential is most likely 
hidden in the determination of the structure of the proteins incorporated in the 
particle. In the past, the structure of proteins embedded in HDL particles was 
determined by nuclear magnetic resonance spectroscopy (NMR) (Kijac et al., 2007). 
However, rHDL were also successfully used for structure determination via Cryo 
electron microscopy (Cryo EM) (Matthies et al., 2018). 
The preparation of rHDL particles is a key method for paper IV. Purified 
FZD6 was reconstituted into rHDL particles with and without heterotrimeric 
G protein in order to quantify the receptor’s GEF activity using a [35S]GTPγS binding 
assay.  
3.5 [35S]GTPγS assay 
Many functional assays for GPCRs depend primarily on the measurement of 
G protein-mediated generation of the second messengers such as cAMP or 
inositolphosphate or downstream signalling such as calcium mobilization or kinase 
activation. However, measurement of events proximal to the receptor activation can 
be advantageous, because the signal is not influenced by the additional downstream 
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amplification or regulation. One of the earliest processes following GPCR stimulation 
is a heterotrimeric G protein activation, which can be measured by the [35S]GTPγS 
assay.  
GPCRs form a ternary complex consisting of its ligand occupying the 
extracellular part of the receptor and a G protein binding from the intracellular side. 
After agonist stimulation, the activated GPCR facilitates the exchange of guanidine 
diphosphate (GDP) for guanidine triphosphate (GTP) on the α-subunit of the 
heterotrimeric G protein. This in turns leads to conformational changes in both 
receptor and heterotrimeric G proteins, which result in dissociation of the α-subunit 
from βγ and mediation of the signal to other downstream components.  
The [35S]GTPγS assay measures the exchange of GDP to GTP facilitated by 
GPCR activation. The signal is based on the non-hydrolysable analogue of GTP, 
where the γ oxygen in GTP is substituted by a radioactively labelled sulphur [35S]. 
This modification renders GTP resistance to hydrolysis by the GTPase activity of the 
α-subunit, so it stays bound to the receptor.  
The assay is more suitable for GPCRs coupled to Gi/o because of the high 
exchange rate of GDP for GTP but has also been used for other types of heterotrimeric 
G proteins (Milligan, 2003). In the classical format of the assay, the bound 
[35S]GTPγS is measured after separation from free nucleotides by filtration on filter 
plates. The radioactivity captured on a filter plate is quantified by scintillation after 
addition of the scintillation cocktail. 
We employed the measurement of G protein activation for the receptor 
embedded in the rHDL particles in paper IV.  
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4 RESULTS AND DISCUSSION 
4.1 WNT signalling in centrosomal events 
(Paper I) 
WNT signalling is known to promote the cell cycle through stimulation of 
gene expression of cyclin D and c-myc, which enables the cells to pass the G1/S 
checkpoint. However, it now seems that WNT signalling can regulate the cell cycle 
not only by transcriptional activation, but also by the direct association with 
centrosomal proteins and proteins playing role in the cell division.  
Over the years, it has been observed that many components of the WNT 
pathway change expression during the cell cycle progression. Many of them, such as 
β-catenin (Olmeda et al., 2003), AXIN (Kim et al., 2009), AXIN2 (Hadjihannas et 
al., 2012), DVL (Kikuchi et al., 2010) and APC (Dikovskaya et al., 2004), peak in 
the G2/M phase during the cell cycle. The main focus of the study was DVL biology, 
so we performed the cell sorting based on the cell cycle phases and stained individual 
fractions with a DVL3 antibody. We observed that DVL reaches the peak in the G2/M 
phase. Interestingly, it has been reported that a response of the FZD co-receptor LRP6 
to WNTs is maximal also during the G2/M phase  (Davidson et al., 2009). In G2/M, 
LRP6 undergoes a priming phosphorylation via a Cyclin Y/CDK14 complex 
increasing its sensitivity to WNTs. Initially, it was thought that this phosphorylation 
results in a β-catenin stabilization and therefore promotes WNT/β-catenin signalling 
during the G2/M phase. Lately it was proposed that this event might be part of the 
WNT/STOP (Stabilization of proteins) signalling (Acebron et al., 2014). This 
pathway results in an inhibition of GSK-3β upon WNT stimulation, and since GSK-
3β phosphorylates a plethora of proteins, which targets them for degradation, its 
inhibition results in a protein accumulation as a preparation for cell division. 
However, our and other reports suggest that apart from passive accumulation of 
proteins, the WNT signalling components have a functional and regulative role in the 
centrosomal biology.  
Manipulating levels of DVL in the cell induces phenotypes, which could be 
connected to aberrant cell division or centrosomal function. SiRNA for DVL 
decreases the proliferation of cells and we assume this is caused by the failure 
of centrosomes to separate. On the other hand, the overexpression of DVL induces 
50 
formation of multinucleated cells. Such a phenotype is typically a consequence of 
an imbalance of centrosomal proteins including NEK2, Aurora A, PLK1, PLK4 and 
γ-tubulin (Tillement et al., 2009).  
We also performed mass spectrometry analysis for the identification of novel 
DVL binding partners. Some of the identified proteins could be grouped according to 
their functions, thus suggesting a novel role of DVL in biological processes, such as 
DNA damage repair, spermatogenesis and centrosomal events. We decided to 
investigate the role of DVL in the centrosomal biology further. 
First, we aimed to investigate the localization of endogenous DVL in cells. 
The overexpressed DVL creates distinct cytoplasmic puncta (Schwarz-Romond et al., 
2007b), but a staining for endogenous DVL has been rather challenging. By utilizing 
low expression constructs, DVL was previously reported to be present at the spindle 
poles, the midbody (Kikuchi et al., 2010) and basal bodies (Park et al., 2008). We 
observed the DVL localization to the centrosome, which was mediated via the DIX 
domain, similar to what was reported for AXIN before (Alexandrova and Sokol, 
2010). Additionally, several other proteins such as β-catenin (Bahmanyar et al., 2008; 
Huang et al., 2007) and kinases, such as CK1a and CK1e were observed in the 
centrosome (Greer and Rubin, 2011; Milne et al., 2001; Stöter et al., 2005).   
For several centrosomal proteins, which were identified by mass 
spectrometry as interaction partners of DVL, we confirmed their association to DVL 
by co-immunoprecipitation (co-IP). First, we investigated further DVL interaction 
with the centrosomal kinase NEK2. We found out that this interaction is mediated 
by the PDZ domain of DVL. We also analyzed the phosphorylation of DVL induced 
by NEK2 by mass spectrometry, which revealed many phosphorylation sites in DVL2 
(27 sites) and DVL3 (41 sites), from which several are phosphorylated directly by 
NEK2, further suggesting that NEK2 regulates DVL activity. Meanwhile, the 
interaction of NEK2 and DVL was reported in functional screens in Drosophila 
(Schertel et al., 2013). In agreement with our findings, they also identified DVL as 
a substrate of NEK2 and the authors suggested that the interaction of DVL to NEK2 is 
dependent on its central part, which contains the PDZ domain (Schertel et al., 2013). 
Next, we tested the interaction of DVL with other proteins of the centrosomal 
linker. A co-IP of C-NAP1 and CDK5RAP2 with DVL revealed a weak association, 
however, the interaction was strongly promoted by overexpression of NEK2. In 
agreement with this, we observed that an overexpression of DVL can displace these 
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proteins from the centrosome, a phenotype that was rescued by NEK2 knock-down. 
A similar mechanism was described earlier, where C-NAP1 was removed from the 
centrosome after the co-expression of NEK2 (Mayor et al., 2002). It seems that DVL 
serves as a scaffold protein in the loose centrosomal linker and undergoes 
a displacement from the centrosome upon NEK2 phosphorylation due to a change in 
DVL surface charge.   
β-catenin is another component of WNT signalling, which is associated to 
the centrosomal linker. However, instead of an interaction with C-NAP1 and 
CDK5RAP2, it rather interacts with another linker protein, Rootletin (Bahmanyar et 
al., 2008). β-catenin is also phosphorylated by NEK2, but instead of degradation, it 
leads to its accumulation at the centrosome (Mbom et al., 2014) and β-catenin 
depletion increases the number of unseparated centrosomes, resulting in monopolar 
mitotic spindles (Kaplan et al., 2004). Another WNT signalling protein associated to 
the centrosome function is AXIN. Its loss leads to a centrosomal splitting 
(Hadjihannas et al., 2010).  
A previous study reported that NEK2 serves as a strong enhancer of the WNT 
signalling pathway (Schertel et al., 2013). However, we were not able to observe any 
increase of WNT/β-catenin signalling via TOPFlash caused by overexpression of 
NEK2 itself, only in synergy with CK1. In contrast, removal of NEK2 by siRNA 
decreased WNT signalling. We hypothesized that NEK2-induced displacement of 
DVL from the centrosome increases the available pool of DVL in the cytoplasm. 
Thus, it is likely that NEK2 can positively influence WNT/β-catenin signalling 
indirectly by releasing more DVL, which can then signal in the WNT pathway. NEK2 
can represent a novel regulatory mechanism influencing the intensity of WNT 
signalling and could connect it to both the centrosomal regulation and the cell cycle 
biology.  
4.2 WNT signalling in angiogenesis of the CNS 
(Paper II) 
Many developmental and physiological processes require WNT signalling. 
One such processes is the development of the vasculature in CNS, where WNT 
signalling regulates sprouting of new blood vessels and establishment of BBB. 
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The requirement of WNT signalling for the initiation of the CNS 
angiogenesis was demonstrated in the brain endothelial cells (Daneman et al., 2009; 
Liebner et al., 2008). Various WNTs were detected in different areas of the 
developing CNS, with WNT-1, -3, -3A, -4 being expressed dorsally and WNT-7A 
and WNT-7B ventrally (Parr et al., 1993). Mice lacking WNT-7A/B are 
embryonically lethal at E12.5 because of a lethal disorganization of the neural tissue  
and an extensive haemorrhage (Stenman et al., 2008). The perineural vascular plexus 
is established normally, but it fails to reach the neural tissue, especially on the ventral 
side. Thus, WNT proteins serve as a potent migration signal in the CNS endothelial 
cells (Daneman et al., 2009).  
A similar phenotype with defective vessel sprouting into the CNS was caused 
by depletion of β-catenin. Since β-catenin is one of the components in adherent 
junctions (Meng and Takeichi, 2009), it can be argued that its removal contributes to 
the haemorrhagic phenotype by destabilization of cell contacts (Cattelino et al., 
2003). However, this does not seem to be the case, because the defects in the CNS 
vasculature (i) correspond only to the area where the WNT/β-catenin pathway is 
activated and (ii) are further caused by injecting the WNT/β-catenin pathway 
inhibitor affecting only β-catenin available for signalling but not influencing 
β-catenin in junctions (Daneman et al., 2009). Overall, we can conclude that WNT-
7A and 7B are expressed by the neuronal cells to promote CNS vascularization by 
activating WNT/β-catenin signalling in endothelial cells.  
A previous study indicated that endothelial cells of the CNS express FZDs 
mRNA (FZD4, FZD6 and FZD10) at the onset of the angiogenesis (Hupe et al., 2017). 
FZD4 has been previously connected to the retinal angiogenesis (Xu et al., 2004), 
where null mutation of FZD4 or its ligand Norrin abrogated WNT signalling and 
caused the absence of intraretinal capillaries and defects in vascular patterning 
(Dejana, 2010; Ye et al., 2009). In the retina and the brain, FZD4 helps to maintain 
the integrity of the BBB and the blood-retina barrier (BRB) (Wang et al., 2012). 
Additionally, both overactivation and loss of function of FZD4 in mouse result in 
early embryonic lethality due to defects in vascular organization (Ye et al., 2009).  
We decided to investigate the signalling aspects of FZD10. The FZD10 mRNA 
is highly expressed in endothelial cells at the time of CNS angiogenesis. In situ 
hybridization experiments and immunostainings of FZD10 together with the typical 
endothelial marker, platelet endothelial cell adhesion molecule-1 (PECAM-1) 
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resulted in a colocalization in specific parts of the CNS of mouse embryo in E11.5 
and E12.5. We showed that FZD10 forms the preassembly complex selectively with 
heterotrimeric G protein G13. Interestingly, G13 was shown to play a crucial role in 
the CNS angiogenesis. The G13 knock-out mice, as well as G13 endothelial specific 
knock out mice die in utero due to disorganized vasculature (Offermanns et al., 1997; 
Ruppel et al., 2005). However, the specifics of G13 downstream signalling in 
angiogenesis are not known.  
Previously, it has been reported that one of the downstream signalling 
pathways of G13 can be YAP/TAZ signalling (Yu et al., 2012), known also as the 
Hippo pathway. This pathway controls the size of the organs and malfunction of the 
components of the Hippo pathway leads to a hippopotamus-like phenotype (Zhao et 
al., 2010). The YAP/TAZ signalling pathway represents an important regulator of 
angiogenesis by participating in regulation of endothelial cells proliferation (Shen 
and Stanger, 2015). Furthermore, overexpression of YAP enhances angiogenic 
sprouting and increases expression of angiopoietin 2, a molecule important for 
angiogenesis and vascular remodeling (Choi et al., 2015).  
In addition to its role in angiogenesis in the CNS, WNT signalling plays 
a role in the establishment of the BBB. The expression of the BBB-specific protein 
GLUT-1 was induced by WNT-7A/B in endothelial cells (Daneman et al., 2009; 
Stenman et al., 2008). Additionally, activated WNT/β-catenin signalling repressed 
the immature brain vessel markers (Liebner et al., 2008). As mentioned previously, 
FZD4 and Norrin signalling were also shown to be necessary for maintenance of 
the BBB (Wang et al., 2012). We showed that FZD10 colocalized with GLUT-1, 
the marker of the BBB. Therefore, we suggest that FZD10 might be involved in 
angiogenesis of the CNS and the establishment of BBB, most likely acting together 
with FZD4. We showed that FZD10 forms a preassembly complex with G13 and that 
FZD10 activates the YAP/TAZ signalling pathway in a G13 dependent manner. 
The FZD10 activation of the YAP/TAZ pathway leading through G13 can be 
complementary to WNT/β-catenin signalling.  
The WNT signalling might play a dual role in angiogenesis. WNT/β-catenin 
signalling can promote angiogenesis by cell proliferation. Further, it can be involved 
in the sprouting and migration of endothelial cells via G12/13 signalling and 
YAP/TAZ. Thus, the deregulation of both WNT/β-catenin-dependent 
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and -independent pathways could have distinct roles in the angiogenic process but 
result in similar angiogenic defects.  
 
4.3 Role of the CRD and the linker domain 
(Paper III) 
Members of the Class FZD possess a large extracellular domain, the CRD, at 
their N-terminus. This bulky domain contains ten conserved cysteines engaging in 
five disulphide bonds and is seen as the main binding 
site for the WNT proteins (Bhanot et al., 1996; 
Povelones and Nusse, 2005) This has been 
structurally confirmed by the generation of the 
crystal structure of XWNT-8 bound to the FZD8-
CRD (Janda et al., 2012). However, the necessity of 
the CRD domain in WNT signalling has been 
challenged by several experiments in vivo. 
Phenotypes typical for defective β-catenin signalling 
in Drosophila embryos, where the genes for FZD 
homologues are mutated and cause disturbed 
segmentation of the cuticle, were rescued by FZDs 
lacking the CRD domain (Chen et al., 2004, 2008; 
Wu and Mlodzik, 2008). However, the PCP 
phenotype, which is represented by disrupted hair 
orientation in the Drosophila wing, was not 
rescued by the ΔCRD FZD (Wu and Mlodzik, 
2008). One of the possible explanations is that the 
CRD is not necessary for WNT/β-catenin 
signalling but it is crucial for WNT/PCP signalling. 
The function of FZD in the PCP pathway might be 
different from β-catenin signalling and the 
transduction of the signal could be dependent on 
the interaction of the CRD with other components 
of the pathway.  
Figure 12. A model of the 
structure, which represents FZD 
bound to the WNT-8 protein. 
The overlay model of FZD is 
based on the SMO structure 
(PDB: 5V57) and the FZD8-
CRD/WNT structure (PDB: 
4F0A). WNT in red, CRD in 
yellow, linker domain in green 
and TM region in grey. 
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Nevertheless, the current understanding 
of CRD/WNT interaction suggests that the CRD 
serves as a high affinity binding platform for 
WNTs bringing them to the close proximity of 
the receptor, which leads to subsequent receptor 
activation. However, how the receptor translates 
the WNT binding into the activation of the TM 
core is still unknown. The WNT protein itself 
might be too large for being inserted or 
associated anywhere in the transmembrane 
domain (Figure 12). A better explanation could 
be extrapolated from the knowledge about SMO, 
where the binding of a small molecule ligand to 
the CRD causes a structural rearrangement in the 
transmembrane domain, which leads to receptor 
activation (Byrne et al., 2016). The recently 
solved structure of FZD4 suggests that the 
extracellular part of the receptor, consisting of the linker domain and ECLs, is very 
compact and therefore such a ‘communication’ between the CRD and TMs might be 
possible (Yang et al., 2018). However, the CRD in the FZD4 structure is missing, 
therefore the overall picture on the arrangement of the receptor’s extracellular part 
might not completely reflect the reality.  
This led us to investigate, whether the CRD is necessary for receptor activity, 
receptor embedding into the plasma membrane or if it exhibits any autoinhibitory 
functions. The function of the CRD was studied in SMO to greater extent, but the 
results are mostly contradictory. The deletion of the CRD resulted in constitutively 
active SMO (Byrne et al., 2016). However, this outcome was not supported by other 
studies, where the removal of SMO-CRD completely abolished the GLI reporter 
activity induced by SMO expression (Rana et al., 2013) (Aanstad et al., 2009) and 
Drosophila SMO mutants were not rescued by SMO lacking the CRD (Nakano et al., 
2004). 
To test the role of the CRD domain for FZD6 functionality and signalling, we 
generated a construct of FZD6, where the CRD domain was deleted (ΔCRD) but the 
construct retained the linker region, the TM core and the C-terminus. First, we 
Figure 13. Surface expression of 
full-length and ΔCRD-FZD6. The 
receptor is stained by FLAG 
antibody added into the media on 
the non-permeabilized cells. 
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showed that such a deletion does not impair the ability of the receptor to be expressed 
at the cell surface (Figure 13). It is in agreement with the previous findings, where 
a  similar truncation did not influence FZD insertion into the plasma membrane 
(Povelones and Nusse, 2005). Unfortunately, since FZD6 is involved in the β-catenin-
independent pathways, no robust assays for testing its functionality are available. 
As an indirect measure of activity, we used the common assays that rely on its 
intracellular interacting partner DVL. The DVL recruitment investigated by 
immunofluorescence revealed that both, full-length and ΔCRD are able to efficiently 
recruit DVL2. Similar results were obtained from the 
electrophoretic mobility shift of DVL. The DVL shift 
can be interpreted as a readout for DVL activation 
(Bernatik et al., 2011), and since DVL plays a role in 
both β-catenin-dependent and -independent 
branches, it is used as a common readout for the 
pathway activation. In agreement with the data from 
immunostaining, we observed DVL shift and hyper 
shift caused by both full length and DCRD. However, 
our data are in contrast to the previously published 
work, where full-length and DCRD FZD6 constructs 
exhibited different behaviour (Golan et al., 2004). As 
a readout, the authors used TOPFlash reporter assay. 
FZD6 cannot stimulate the WNT/β-catenin signalling 
pathway, but the authors reported that full-length but 
not DCRD FZD6 repressed WNT/β-catenin signalling 
activated for example by WNTs or DVL 
overexpression. We repeated the experiment with 
overexpressed full-length and our version of DCRD 
FZD6 and we observed similar decrease of 
WNT/β-catenin reporter activity for both constructs 
(Figure 14). Such a discrepancy in the results could 
be explained by specific location of the truncation in 
the protein sequence. As mentioned above, our 
construct possesses a substantial part of the linker 
domain. The constructs of FZD6, which did not 
Figure 14. The effect of the 
FZD6 expression on WNT/β-
catenin signalling measured 
by TOPFlash luciferase 
reporter assay. FZD6 reduces 
the agonist (WNT-3A) 
induced increase in the 
transcriptional activity 
irrespective of the presence 
of the CRD. The decrease of 
the signal is comparable for 
both, full-length and ΔCRD 
FZD6 construct.  The β2 
adreneric receptor (β2AR) 
was used as a control.  
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exhibit functionality, were lacking the CRD, the linker domain and part of the TM 
core (Golan et al., 2004). The most likely explanation is that such a massive deletion 
impairs the insertion of the construct into the plasma membrane and therefore 
abolishing its function.  
This argumentation is supported by the next set of experiments, where we 
determined a residue in the linker domain that is crucial for the insertion of FZD6 into 
the plasma membrane. This residue in FZD6 corresponds to the C161 and is fully 
conserved in both SMO and all FZDs. In the full-length SMO crystal structure, the 
cysteines in the protein linker are engaged in two disulphide bonds (Byrne et al., 
2016). The C161 forms a disulphide bridge with C181 and C185 interacts with C260 
of ECL1 (Figure 15). Interestingly, just simple substitution of any of the cysteines in 
the linker to alanine completely abolishes the insertion of the receptor into the cell 
surface, which is probably the reason for the receptor’s inability to recruit DVL to the 
plasma membrane and to induce the DVL shift. Interestingly, from the immunoblots 
it is apparent that the FZD6 mutants have impaired posttranslational modifications 
compared to the wild type receptor. The most plausible explanation is that the 
mutation of the cysteines in the linker disrupts the linker structure, which in turn 
prevents proper receptor folding and its 
subsequent insertion into the plasma membrane.  
The importance of the cysteines is 
highlighted by the fact that corresponding 
cysteines in FZD4 are found to be mutated in the 
patients with familial exudative vitreo-
retinopathy (FEVR), a condition characterized 
by impaired vascularization in the retina in the 
eye. The mutation of these residues is linked to 
impaired receptor membrane localization or 
trafficking (Milhem et al., 2014), impaired 
ability to bind the ligand Norrin or impaired 
activation of the WNT/β-catenin pathway (Bang 
et al., 2018; Zhang et al., 2011). The importance 
of the linker domain in signalling and the ligand 
binding was recently confirmed: The CRD of 
FZD4 together with the linker domain exhibited 
Figure 15. The model representing 
FZD6, zoomed to the linker domain 
part (in green). The cysteines and the 
disulphide bonds in the linker 
domain are highlighted in red, the 
numbering corresponds to the 
numbering of FZD6 (the model is 
based on the SMO structure, PDB: 
5V57). 
58 
a ten times higher affinity to Norrin than CRD alone (Bang et al., 2018). Interestingly, 
swapping the linker domain from FZD4 to linker from FZD5 decreased Norrin binding 
and completely abolished Norrin-induced signalling.  
Although previous research did not pay much attention to the linker domain, 
which was originally thought to be rather unstructured (DeBruine et al., 2017), it 
plays a crucial role is several processes. It is responsible for the receptor trafficking 
and insertion to the plasma membrane, as supported by our data in FZD6 and reported 
by others in FZD4 FEVR mutation, and it also participates in high-affinity ligand 
binding, receptor specificity and signal transduction (Bang et al., 2018). In addition, 
crystal structures of SMO indicate that the linker domain is tightly packed between 
the CRD and the TM core (Byrne et al., 2016) where it could function as a signal 
transducer.  
4.4 Frizzleds as GPCRs 
(Paper II and Paper IV) 
The overall architecture of FZDs strongly suggests that they belong to the 
superfamily of GPCRs (Barnes et al., 1998). They possess conserved cysteines in the 
ECL1 and ECL2, which contribute to receptor stability by disulphide bridges. There 
are charged residues, in the ICL3, which could play role in G protein coupling. On 
the other hand, FZDs lack some domains conserved in Class A GPCRs, which are 
necessary for G protein coupling such as the DRY motif in TM3 or the NpxxxY in 
TM7 (Schulte, 2010).  
From a functional point of view, the ability of FZDs to mediate signalling 
independently of heterotrimeric G protein in some experimental setups led to 
concerns about the GPCR nature of FZDs. Even more doubts arose after a recent 
finding that one homologue of FZDs, FZD7, employs a non-receptor GEF protein, 
a DVL-associating protein with a high frequency of leucine residues called DAPLE, 
in order to activate G proteins (Aznar et al., 2015). 
However, there is an overwhelming evidence for the involvement of 
heterotrimeric G proteins in both, β-catenin dependent and -independent signalling 
(Dijksterhuis et al., 2014; Schulte and Wright, 2018). One of the most frequent tools, 
which has been used to explore the heterotrimeric G protein engagement in WNT 
signalling pathways is a treatment by the Bordetella pertussis toxin (PTX), a toxin 
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inhibiting Gi, Go and Gt by ADP rybosylating the alpha subunit (Krueger and 
Barbieri, 1995).  
One of the first experiments reporting an involvement of the heterotrimeric 
G protein in the β-catenin pathway was done in F9 teratocarcinoma stem cells. The 
activation of WNT/β-catenin signalling by WNT-5A and WNT-8 in FZD1 expressing 
F9 cells causes their differentiation into primitive endoderm (Liu et al., 1999). Since 
this effect was blocked by PTX, it pointed to an involvement of G proteins from the 
Gi/o family. Similar experiments were performed with a chimeric receptor, composed 
of the intracellular parts of FZD and the transmembrane/extracellular domains from 
the β2 adrenergic receptor (Liu et al., 2001). The researchers showed that the chimeric 
receptors can be stimulated with adrenergic ligands but would influence downstream 
signalling as FZDs. Work in Drosophila melanogaster also brought a piece of 
evidence for an involvement of G proteins in WNT signalling. Overexpression of Go 
increased the levels of WNT target genes in the Drosophila wing, (Katanaev et al., 
2005). Our group also showed that stimulation of the mouse primary microglia cells 
with WNT-3A increased levels of β-catenin and phosphorylated LRP6 (Halleskog 
and Schulte, 2013). This effect can be diminished by PTX treatment suggesting 
an involvement of Gi/o.  
Even more evidence emerged for the involvement of G proteins in β-catenin-
independent pathways. In the Drosophila wing, the overexpression or depletion of 
Go resulted in impaired hair orientation in the wing, a phenotype typical for the PCP 
pathway (Katanaev and Tomlinson, 2006; Katanaev et al., 2005). Another role of 
G proteins in the PCP pathway was demonstrated in sensory organ precursor cells, 
where the Go was important for both correct positioning of the epithelial plane and 
intrinsic polarity (Gho and Schweisguth, 1998). The connection between the 
WNT/Calcium pathway and G proteins has also been discovered. Zebrafish embryos 
transfected with FZD2, WNT-5A or both exhibited an increase in calcium 
mobilization (Slusarski et al., 1997b), which was inhibited by PTX, again suggesting 
the involvement of Gi/o.  
In addition to the initial studies in cells and in vivo, the association of 
G proteins to FZDs were investigated by in vitro biochemical studies. One of the 
elegant approaches is to test whether FZD and G proteins can create an inactive 
‘preassembly’ state, which is dissociated by addition of agonists. Such a preassembly 
state was shown for FZD9 with Go using immunoprecipitation (Ramírez et al., 2016). 
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Our group successfully employed dcFRAP to investigate whether FZD10 can form 
a preassembly complex. We aimed to test at least one G protein from each subfamily 
(Gi1, Gq, Go, Gs, G12 and G13). In comparison to FZD6, which associates with Gi 
and Gq (Kilander et al., 2014b), FZD4 interacts with G12 and 13 (Arthofer et al., 
2016), and FZD5 with Gq (Wright et al., 2018). The preassembly state of FZD10 was 
specific just for G13 among all the tested G proteins. The receptor-G protein complex 
dissociated after addition of the endogenous agonists WNT-5A and -7A but not 
WNT-3A, highlighting the preference of FZD not only to specific heterotrimeric 
G protein but also to specific WNT in this readout. However, it is important to note 
that these experiments do not exclude interaction of the receptor with other G proteins 
via other mechanisms. Collision coupling can be one of such mechanisms, where the 
receptor and G protein interaction is based on their collision by free diffusion in the 
plasma membrane (Oldham and Hamm, 2008).  
Furthermore, we were able to show the ability of FZD10 to signal through 
heterotrimeric G proteins by another technique – DMR, similarly as we presented for 
FZD4 (Arthofer et al., 2016). The response to WNT-5A and WNT-7A was observed 
in wild type HEK293 cells only when FZD10 was overexpressed. The DMR response 
was lost in cells lacking G12/13, suggesting that FZD10 mediated the DMR response 
through G12/13. A treatment of non-transfected cells with WNT did not produce 
a consistent DMR despite an endogenous expression of most of the FZD homologues 
in HEK293 cells (Atwood et al., 2011). The possible explanation could be that 
endogenous levels of receptors signalling through G12/13 are not sufficient to 
observe a WNT-induced effect.  
All of the abovementioned studies are cell-based, and therefore one can 
always argue for some intermediate cellular component mediating GEF function 
instead of the receptor. This intermediate player can reach sufficient amounts in the 
cells even without overexpression. We therefore decided to investigate the ability of 
FZD6 to activate heterotrimeric G proteins in a reconstituted system, where the 
purified receptor is embedded into the well-defined phospholipid bilayer of a rHDL 
or nanodiscs. The rHDL particles are assembled in vitro, thus the composition of 
rHDL particle is exactly defined. We embedded FZD6 into rHDL particles together 
with the purified heterotrimeric G protein, particularly Gi and Gq. These particles 
were used for a radioactive [35S]GTPγS assay to quantify receptor-mediated 
activation of the G protein. Particles containing both heterotrimeric G protein and 
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FZD exhibited an elevated activation of G proteins in comparison to samples, where 
only G protein was added. The comparison of the activation of Gq and Gi shows 
a larger increase of the signal for Gi, which is known to have a higher rate of basal 
guanine nucleotide exchange than the other G proteins (Milligan, 2003). The elevated 
activation confirms that FZD acts as GEF and can activate the G protein directly. The 
observed increase is caused by the intrinsic GEF activity of the receptor, so-called 
constitutive activity. Our previous data suggests that monomeric receptor exhibits 
higher constitutive activity even in the absence of a ligand (Petersen et al., 2017).  
Due to the technical problems, we were not able to observe a WNT induced 
increase in G protein activation on [35S]GTPγS and these experiments need to be 
repeated. It is possible, that usage of WNTs in this assay will be challenging, as is the 
case for a WNT binding assay. We tried to reconstitute the WNT protein together 
with FZD and G protein, but even this setup did not result in increased G protein 
activation. In case that the technical challenges with WNT treatment remains, they 
could be overcome via creation of a chimeric receptor, where the WNT protein is 
covalently bound to FZD by replacing the CRD. Such a replacement was reported to 
produce a highly constitutively active receptor for WNT/β-catenin signalling 
(Povelones and Nusse, 2005). The WNT-FZD chimeric receptor could in our system 
bypass the necessity of usage of expensive WNTs and can stabilize the active state of 
the receptor. However, the mechanism of agonist binding including measuring the 
affinity cannot be studied in this setup.     
How the interaction between the G protein and FZD is mediated within the 
HDL particles can be explained in several ways: (i) during the reconstitution, the 
heterotrimeric G protein itself is not efficiently reconstituted to the particle without 
the receptor and can fall off, in comparison to the sample where FZD is present and 
the G protein is able to directly associate to the receptor; (ii) the G protein is 
embedded into the particle in both cases, but the coupling and subsequent activation 
of the G protein can occur only in the sample with the receptor. In any case, this 
experiment provides the proof that FZD can bind and activate a heterotrimeric 
G protein in a reconstituted system, excluding participation of any intermediate 
players.  
A complementary result to our finding was published previously, employing 
a bacterial system that naturally lacks the GPCR signalling machinery (Katanaev and 
Buestorf, 2009). In experiments, which aimed to prove that FZDs are functioning as 
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GPCR per se, the commercially produced G protein was added to the bacterial 
membranes with overexpressed human FZD. WNT stimulation induced G protein 
activation and addition of sFRP, proteins sequestering the WNTs thus functioning as 
negative regulators, inhibited the G protein activation.  
Although FZDs can signal independently of heterotrimeric G proteins, we 
showed that they are able to function as a GPCR. Assembly of the inactive G protein 
signalling state cannot argue for the direct interaction but highlights that FZD-
dependent signalling events include a heterotrimeric G protein. However, we showed 
that FZD can directly trigger G protein activation in a unique system of reconstituted 
phospholipid bilayer particles. Further optimization of this assay will hopefully lead 
to its application for screening of FZD modulators.  
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5 GENERAL DISCUSSION 
The WNT signalling pathway is implicated in many pathophysiological 
processes and is therefore seen as a promising target for pharmaceutical intervention. 
The research presented in this thesis focuses on the less investigated functions of WNT 
signalling, with two main signalling molecules of the WNT signalling pathway in focus 
– the cytoplasmic protein DVL and the membrane receptor FZD. We further extend the 
knowledge about the role of DVL for the functionality and regulation of the centrosome 
and the centrosomal cycle. Moreover, we investigated the ability of FZDs to signal 
through and directly activate heterotrimeric G proteins and we also elucidated the role 
of the poorly described linker region of FZD connecting the extracellular CRD domain 
and the receptor core.  
The connection of WNT signalling to the centrosome and the centrosomal 
cycle has been emerging over the last years. The general notion appeared after the 
finding that many of the key players of the WNT signalling pathway localize to the 
centrosome or centrosome-associated structures, such as the basal bodies (Bryja et al., 
2017). However, a fundamental understanding of the underlying mechanisms of WNT 
signalling during various centrosomal events is still missing, leaving many questions 
unanswered. For example, is WNT signalling regulating the centrosomal events or vice 
versa, do centrosomal events influence the intensity or the efficacy of WNT signalling? 
Is it just a coincidence that many WNT signalling proteins are localized at the 
centrosome? Do they have a specific function in the centrosome? Results in this thesis 
do not answer all these questions but contribute to elucidate a part of the complex WNT 
signalling mosaic.  
We have shown that DVL plays a role in the centrosome separation as a part 
of the loose centrosomal linker. Interestingly, other proteins involved in WNT 
signalling, such as β-catenin and AXIN, were also shown to participate in the 
centrosomal separation (Kim et al., 2009; Mbom et al., 2014). This naturally raises the 
question, whether the role of WNT signalling is instructive, or whether the individual 
proteins act alone and not in a coordinated manner. Do WNT signalling proteins exist 
in distinct non-overlapping pools (at the centrosome, in the cytoplasm or at the 
membrane), or is there a bustling communication going on? If there is indeed some 
communication, does it have an effect on the outcomes of WNT signalling such as level 
of activation or even WNT/β-catenin-dependent and independent pathway switching? 
We have shown that the release of DVL from the centrosome might increase its 
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availability for functioning in the β-catenin-dependent WNT signalling. However, if 
the centrosomal cycle is more globally connected to WNT signalling outcome remains 
to be described.  
Part of the study closely investigated the main receptor for WNTs, FZD. The 
knowledge of how FZDs function is still one of the biggest mysteries in WNT 
signalling. The research is complicated by several facts, most relevant being the lack of 
assays detecting the direct activation of FZDs or ligand-FZD binding. Until now, the 
assays most commonly monitor events downstream of receptor activation but suffer 
from possible signal amplification or suppression by intermediate players. Any of the 
co-receptors, kinase cascades, second messengers or scaffold proteins can change the 
signalling output. The long-term aim of our laboratory is to develop assays monitoring 
the direct activation of FZDs. In addition to the presented [35S]GTPγS assay utilizing 
the rHDL particles with the embedded receptor, we have constructed Förster resonance 
energy transfer (FRET) probes for another FZD homologue, FZD5. The probes reflect 
conformational changes upon receptor stimulation and present the first direct 
measurement of WNT-induced structural changes of FZD (Wright et al., 2018). This 
methodology presents a direct consequence of a ligand binding in form of a con-
formational change and is thereby complementary to a putative ligand binding assay 
and the [35S]GTPγS  assay presented in the paper IV and [35S]GTPγS assay performed 
on cell membranes (Kilander et al., 2011a, 2011b; Koval and Katanaev, 2011).    
The development of assays for monitoring direct receptor activation greatly 
contributes not only to understanding of the receptor activation mechanism, but it also 
helps to overcome another obstacle: it enables the screening of ligands suitable for 
biochemical and pharmacological assays. WNT proteins that serve as FZD ligands are 
lipidated and their production, purification and usage are expensive and challenging as 
a result of the lipid moieties. However, a reliable assay monitoring the direct receptor 
activation is one of the prerequisites for small molecule or other ligand screening. It is 
very difficult to exit this vicious circle. The situation is even more complicated by the 
many possible interactions between 19 WNTs and ten FZDs, which are only partially 
elucidated. However, it is clear that specific WNTs can signal through multiple FZDs 
and similarly one FZD can be activated by multiple WNTs (Dijksterhuis et al., 2015). 
It should also be noted that there is a degree of functional redundancy among the FZD 
homologues. Unfortunately, cell lines and tissues usually express multiple FZDs and 
therefore it is difficult to dissect their individual contributions.  
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Our main finding of the work presented in this thesis support the evidence that 
FZDs behave as classical GPCRs, in other words that they can directly activate 
heterotrimeric G proteins. The doubts about their GPCR nature arose due to their ability 
to signal independently of heterotrimeric G proteins as well as previously mentioned 
obstacles. We demonstrated in a completely isolated system of rHDL particles that 
FZD6 can activate G proteins with its intrinsic constitutive activity. Developing an assay 
to directly monitor the signalling outcome of FZD can greatly improve our 
understanding of FZDs and can contribute to the development of new FZD modulators. 
Moreover, we showed that embedding functional FZDs into rHDL particles is possible. 
Apart from the use of rHDL particles in biochemical and pharmacological assays, they 
might enable us to elucidate the full-length structure of FZD. FZDs embedded in rHDL 
particles could be visualized by Cryo EM, a technique becoming more popular for 
proteins that resist crystallization. Although FZD4 has been recently crystallized, the 
assessment of the full-length structure via Cryo EM requires smaller amounts of protein 
and could provide a possibility to visualize FZDs in a complex for example with a 
heterotrimeric G protein or WNT proteins.  
During the optimization of the purification procedure, we noticed the presence 
of several truncation products. We do not know whether they are physiologically 
relevant, however, we decided to test their functionality. We designed and created 
several truncation products and found out that the linker region in FZD6 was critical for 
receptor presence in the plasma membrane. Surprisingly, the corresponding cysteine 
residues in this region, which are responsible for the presence of the receptor in the 
plasma membrane, are found to be mutated in the FZD4 homologue, causing 
an impaired retinal development. The recent finding that the linker region increases 
Norrin affinity to FZD4 and determines their specificity (Bang et al., 2018) raises the 
interesting idea that in case of FZDs, the ligand specificity is not determined by the 
CRD but by the linker region.  
To conclude, the improved understanding of the signal transduction and 
regulation of the WNT signalling pathway will shed light on basic mechanisms in 
development and disease progression. Moreover, understanding the molecular details 
of receptor activation and dynamics allows the development of small molecule drugs 
targeting FZDs with more precision with regard to the receptor-mediated signal 
initiation, pathway selectivity and less side effects.  
 
66 
  
67 
 
6 CONCLUSIONS 
 
• DVL is a part of the centrosomal linker and regulates centrosomal 
separation 
• FZD10 establishes a preassembly complex with heterotrimeric G13 
• The downstream signalling pathways of FZD10 involve G13, 
YAP/TAZ and can potentially be involved in angiogenesis of the 
CNS 
• The cysteines in the linker region of FZD6 are necessary for receptor 
embedding into the plasma membrane and for its proper functionality 
• DVL and the isolated DEP domain interact with FZD6 independently 
of agonist stimulation 
• Embedding FZD6 into rHDL particles allows assessment of their 
GEF activity using the [35S]GTPγS assay 
• Monomeric and purified FZD6 is able to activate heterotrimeric 
G proteins, particularly Gi1, with its constitutive activity 
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